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last decades. the post-world war ii baby boom 
further raised the today prevalence of elderly 
in western countries.1 this, combined with the 
decrease of contraindications to major surgical 
advances in health care treatment have con-tributed to increase life expectancy in the 
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BacKgroUND: the number of elderly patients undergoing major surgical interventions and then needing admission to 
intensive care unit (ICU) grows steadily. We investigated this issue in a cohort of 232,278 patients admitted in five years 
(2011-2015) to 163 italian general icUs.
MetHoDs: surgical patients older than 75 registered in the giViti MargheritaProsaFe project were analyzed. the 
impact on hospital mortality of important chronic conditions (severe coPD, NYHa class iV, dementia, end-stage renal 
disease, cirrhosis with portal hypertension) was investigated with two prognostic models developed yearly on patients 
staying in the icU less or more than 24 hours.
resUlts: 44,551 elderly patients (19.2%) underwent emergency (47.3%) or elective surgery (52.7%). at least one 
severe comorbidity was present in 14.6% of them, yielding a higher hospital mortality (32.4%, vs. 21.1% without severe 
comorbidity). in the models for patients staying in the icU 24 hours or more, cirrhosis, NYHa class iV, and severe coPD 
were constant independent predictors of death (adjusted odds ratios [ors] range 1.67-1.97, 1.54-1.91, and 1.34-1.50, 
respectively), while dementia was statistically significant in four out of five models (adjusted ORs 1.23-1.28). End-stage 
renal disease, instead, never resulted to be an independent prognostic factor. For patients staying in the icU less than 24 
hours, chronic comorbidities were only occasionally independent predictors of death.
CONCLUSIONS: Our study confirms that elderly surgical patients represent a relevant part of all ICUs admissions. 
about one of seven bear at least one severe chronic comorbidity, that, excluding end-stage renal disease, are all strong 
independent predictors of hospital death.
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sion, failures and diseases during the icU stay, 
major procedures and interventions, icU and 
hospital outcomes. study homogeneity and 
data quality were assured by a complex and 
standardized set of operating procedures. Data 
concerning patients admitted to general icUs 
between 2011 and 2015 were considered. We 
selected geriatric patients with 75 years or 
more who had undergone a surgical procedure 
within seven days before, the same day of, or 
the day after icU admission. We divided this 
sample in subsets according to their surgical 
status: elective surgery with planned icU ad-
mission, elective surgery with unplanned icU 
admission, and emergency surgery, and on the 
presence of debilitating chronic conditions, 
that we labeled chronic end stage diseases 
(CEDs), as classified by the Charlson Comor-
bidity index:10 severe chronic obstructive pul-
monary disease (COPD) defined as dyspnoea 
at rest, despite treatment, oxygen therapy at 
home, hypercapnia, or severe chronic hy-
poxia; class iV heart failure according to the 
New York Heart association (NYHa) clas-
sification;11 cirrhosis with portal hypertension 
with or without bleeding; end-stage renal dis-
ease defined as established kidney failure with 
glomerular filtration rate <15 mL/min/m² or 
permanent renal replacement therapy; demen-
tia defined as any condition characterized by 
an acquired, persistent alteration of cognitive 
skills impairing daily activities.
Statistical analysis
We used proportions, median and interquar-
tile ranges, means and standard deviations as 
descriptive statistics. 95% test-based confi-
dence intervals were computed for each esti-
mate of interest. Relative risks and their confi-
dence intervals were calculated for unadjusted 
mortality rate comparisons. We performed bi-
variate analyses using the t-test for quantita-
tive variables and the z-test and the χ2 test for 
qualitative variables. We considered an alpha 
value less than 0.01 for the rejection of the null 
hypothesis.
For benchmarking purposes, every year two 
multivariable logistic regression models are fit-
interventions for older people, have caused the 
rate of elderly undergoing surgical interven-
tions to continuously grow.2 However, great 
attention should be paid in the selection and 
perioperative management of these patients, 
as they are at the highest risk of death, espe-
cially when bearing debilitating chronic condi-
tions.3-7 in this context the role of the intensive 
care unit (icU) is crucial for both elective- and 
emergency-surgery procedures.8 Moreover, 
since most of these patients are admitted to the 
icU at least for postoperative monitoring, the 
icU represents a privileged vantage point for 
epidemiologic observation and outcome eval-
uation of this population.
in italy a large research network of inten-
sive care units (icUs) has been operative since 
1991 (giViti - italian group for the evalua-
tion of interventions in intensive care Medi-
cine).9 since 2002 giViti is coordinating the 
international MargheritaProsaFe project, 
currently involving 256 icUs, to evaluate and 
improve the quality of care in this field. We 
used the giViti italian database to investigate 
a population of geriatric surgical patients car-
rying chronic diseases in an advanced phase, 
who had been admitted to the icU for post-
operative management. our aim was to offer 
an epidemiological sight of the italian setting 
and to assess the prognostic impact of chronic 
organ failures in geriatric patients undergoing 
surgery.
Materials and methods
the protocol concerning the data collec-
tion was submitted to the institutional review 
Board of the Hospital “alessandro Manzoni” 
in lecco that, given the observational and ret-
rospective nature of the study, in accordance 
with italian law, waived the need for a formal 
approval.
the italian icUs that join the Margheri-
taProsaFe Project use the same software to 
collect data relative to all patients they have 
admitted. the electronic case-report form in-
cludes demographics, admission diagnoses, 
comorbidities, surgical status, reasons for 
admission, physiologic parameters on admis-
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presence of end-stage chronic conditions (yes/
no variable) in elderly patients. For each pa-
tient we used the individual expected mortal-
ity provided by the appropriate model (e.g., 
the 2012 prognostic model for 2012 patients) 
to build the corresponding specific calibration 
belt and roc curve for each surgical subset 
including patients from 2011 through 2015. 
this approach was adopted to assess whether 
the variables included in the general prognos-
tic models (developed on the entire giViti co-
hort) maintained their predictive ability in the 
six subgroups.
all statistical analyses were performed with 
packages for r version 3.2.5.16
Results
as illustrated in Figure 1, overall, 232,278 
patients admitted to 163 italian general icUs 
in 2011, to 178 in 2012 and 2013, to 171 in 
2014, and to 167 in 2015, participating to the 
MargheritaPROSAFE Project, fulfilled the cri-
teria for inclusion in the prognostic models. of 
these patients 44,551 (19.2%) were surgical, 
75 years old or more, submitted to emergency 
(47.3%) or elective surgery (52.7%). in the lat-
ter group, admission to the icU was planned in 
77.5% of cases and unplanned in 22.5%. over-
all 6507 (14.6%) bore at least one ceD, with 
a higher rate in the emergency-surgery subset 
compared to the other two subsets (P<0.001, 
table i).
almost all icU admissions occurred on the 
same day after elective surgery with scheduled 
icU admission (table i). among those with 
unplanned icU admission, instead, the propor-
tion of patients who underwent surgery on a 
day different from the day of icU admission 
were 24.3% and 18.3% for patients with and 
without CEDs (P<0.001). For emergency sur-
gery patients the proportions were 13.9% and 
15.4% (table i, P=0.024).
among elective-surgery patients with 
planned icU admission, abdominal interven-
tions were the most performed, more frequent-
ly in those without ceDs (40.8% and 46.7% in 
patient with and without ceDs, P=0.001), fol-
lowed by orthopaedic surgery that was preva-
ted to predict hospital mortality on the cohorts 
of patients staying in the icU less and more 
than 24 hours (the development procedure is 
reported in online supplementary Material 1). 
as summarized in Figure 1, we excluded from 
the prognostic models development dataset pe-
diatric and cardiosurgical patients, and patients 
admitted for palliation, and those admitted to 
the icU in months in which the proportion of 
patients with incomplete data exceeded 10%, 
so as to exclude months in which a selection 
bias could have occurred. all data describing 
patients’ conditions on admission, including 
the five covariates object of this study (severe 
coPD, NYHa class iV, dementia, end-stage 
renal disease, cirrhosis with portal hyperten-
sion) were considered as potential covariates.
the area under the receiver operating 
characteristic (roc) curve was used to meas-
ure the discrimination of the model, while cali-
bration was assessed with the giViti calibra-
tion test and belt for model development.12-15 
in brief, the calibration test indicates if there 
are overall statistically significant differences 
between observed and predicted (by the mod-
el) death rates. the calibration belt, instead, 
offers a visual representation of the calibration 
in a plot reporting predicted mortality on the 
x-axis and observed mortality on the y-axis.14 
When the calibration belt does not include the 
bisector (the line of perfect correspondence 
between observed and predicted deaths) a sta-
tistical significant deviation is present. This 
tool is crucial to test the model and assess the 
effectiveness of inclusion of interaction terms 
during the development phase.
the giViti calibration test and belt for 
model validation were also used to evaluate 
the uniformity of fit across subsets defined by 
the variables eventually included in the mod-
els. interactions driven by clinical reasoning 
were tested to improve the fit in subgroups 
where the model proved to miscalibrate.13 in 
this study we evaluated the calibration and 
discrimination of the models on the six pre-
defined subsets, obtained by combining surgi-
cal status (elective surgery with planned icU 
admission, elective surgery with unplanned 
icU admission, emergency surgery) with the 
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cy-surgery subsets (Table I, P<0.001 for both 
comparisons). in these two subsets, instead, de-
mentia was largely prevalent with similar rates 
(46.1% and 49.1% in elective-surgery patients 
with unplanned admission and in emergency 
surgery patients, respectively) compared to 
elective-surgery patients with planned admis-
sion (30.8%, P<0.001).
end-stage renal disease and cirrhosis with 
portal hypertension were less frequent and 
evenly distributed across the three surgical 
subsets (P=0.28 and 0.08, respectively).
on admission to the icU, patients with 
ceDs were overall more severe as witnessed 
by the higher expected mortality rates pre-
dicted by our prognostic models, and by the 
higher median Simplified Acute Physiology 
score (saPs) ii and sequential organ Failure 
assessment (soFa) score values (table ii, P 
values all <0.001).17, 18 However, the need for 
lent in patients with ceDs (28.8% vs. 17.0%, 
P<0.001).
in patients with ceDs, unplanned icU ad-
missions after elective surgery followed main-
ly orthopaedic interventions (43.8%) followed 
by abdominal surgery (30.7%). in those with-
out ceDs, instead, orthopaedic procedures 
were less frequent (31.2%, P<0.001) with a 
comparable rate of abdominal interventions 
(34.3%, P=0.07).
abdominal interventions were by far the 
most frequent among patients admitted af-
ter emergency surgery with a slightly higher 
rate in patients with ceDs (65.3% vs. 61.2%, 
P<0.001).
severe coPD and NYHa class iV affected 
44.0% and 14.2% of patients with planned 
icU admission after elective surgery, and were 
prevalent compared to the elective-surgery 
with unplanned icU admission and emergen-
Figure 1.—Flow diagram for the selection of patients from the giViti database.
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ability and calibration (online supplementary 
Material 1).
the severe coPD, NYHa class iV, and cir-
rhosis were independent predictors of death in 
the five models developed for patients staying 
in the icU at least 24 hours (Figure 2). De-
mentia was instead an independent predictor 
of hospital death in four of the five models that 
covered the study period (Figure 2).
end-stage renal disease never ended up to 
be an independent prognostic factor during the 
study period, whereas age was always so.
While the models discriminated well in all 
the surgical subsets, they calibrated well only 
in five of the six subsets defined by the combi-
nation of each of the three surgical groups with 
or without ceDs (online supplementary Ma-
terial 2). in the emergency-surgery with ceDs 
subset the model miscalibrated in the first de-
cile, specifically for patients with an expected 
hospital mortality predicted by the model in 
the range between 2% and 11% (giViti cali-
bration test P=0.027).
intensive treatment on admission to the icU 
was comparable between patients with and 
without ceDs in the emergency-surgery subset 
(61.3% vs. 60.0%, P=0.15), while it was prev-
alent among patients bearing advanced chronic 
comorbidities in the elective-surgery patients 
with unplanned (51.1% vs. 40.9%, P<0.001) 
and planned (17.9% vs. 12.8%, P<0.001) ICU 
admission.
icU and post-icU discharge mortality 
were lower for elective-surgery patients with 
planned icU admission, and progressively in-
creased in patients with unplanned admission 
and in those submitted to emergency surgery. 
Within each subset, the presence of ceDs sig-
nificantly increased mortality (Table II).
Prognostic weight assessment of end-stage 
chronic diseases
The ten models (patients’ length of stay ≥24 
and <24 hours for every year of the study pe-
riod) were robust with good discriminative 
Table I.—Main features of the three surgical subsets. Patients with and without advanced chronic diseases are com-
pared. Absolute numbers are reported followed by percentages in brackets, unless differently specified.
elective surgery with planned 
admission (N.=18201)






















age – mean (sD) 81.5 (4.8) 80.7 (4.5) 82.3 (4.8) 81.2 (4.7) 82.6 (4.9) 82.2 (5.0)
Male 1407 (61.4) 9282 (58.3) 328 (50.1) 2318 (49.9) 1826 (51.3) 8913 (51.0)
trauma 449 (19.6) 1161 (7.3) 196 (29.9) 697 (15.0) 511 (14.3) 2757 (15.8)
surgery the same day of 
admission
2235 (97.6) 15625 (98.2) 496 (75.7) 3793 (81.7) 3067 (86.1) 14,797 (84.6)
abdominal surgery 934 (40.8) 7430 (46.7) 201 (30.7) 1594 (34.3) 2325 (65.3) 10,699 (61.2)
Vascular surgery 198 (8.6) 1825 (11.5) 49 (7.5) 441 (9.5) 290 (8.1) 1969 (11.3)
orthopedic surgery 659 (28.8) 2699 (17.0) 287 (43.8) 1450 (31.2) 487 (13.7) 1662 (9.5)
Nephro-urologic surgery 252 (11.0) 2081 (13.1) 64 (9.8) 559 (12.0) 94 (2.6) 592 (3.4)
severe coPD 1007 (44.0) 0 (0) 214 (32.7) 0 (0) 1104 (31.0) 0 (0)
NYHa class 4 325 (14.2) 0 (0) 68 (10.4) 0 (0) 383 (10.8) 0 (0)
Dementia 706 (30.8) 0 (0) 302 (46.1) 0 (0) 1750 (49.1) 0 (0)
end-stage renal failure 171 (7.5) 0 (0) 42 (6.4) 0 (0) 289 (8.1) 0 (0)
cirrhosis with portal 
hypertension
216 (9.4) 0 (0) 57 (8.7) 0 (0) 277 (7.8) 0 (0)
Moderate coPD 280 (12.2) 3835 (24.1) 92 (14.0) 875 (18.8) 463 (13.0) 3383 (19.3)
NYHa class 2 - 3 403 (17.6) 2495 (15.7) 101 (15.4) 547 (11.8) 569 (16.0) 2566 (14.7)
any tumour without metastasis 526 (23.0) 4478 (28.1) 122 (18.6) 998 (21.5) 405 (11.4) 2356 (13.5)
chronic arrhythmia 663 (29.0) 3946 (24.8) 188 (28.7) 1098 (23.6) 1076 (30.2) 5112 (29.2)
Diabetes type ii (not requiring 
insulin)
175 (7.6) 2371 (14.9) 84 (12.8) 607 (13.1) 437 (12.3) 2218 (12.7)
Myocardial infarction 486 (21.2) 3425 (21.5) 81 (12.4) 659 (14.2) 570 (16.0) 2667 (15.2)
SD: standard deviation; COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association Classification.
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Discussion
as life expectancy increases, the probabil-
ity of developing diseases that require surgical 
procedures also grows.19 Our study confirms 
this result with 19.1% of all the patients that 
matched the criteria for inclusion in the prog-
nostic model development cohort, having 75 
years or more and being admitted to the icU 
after surgery. the burden of comorbidities 
progressed to advanced stages was high in 
our sample (about one in seven patients bore 
at least one ceD) consistently with literature 
findings.20 severe coPD was common, the 
prevalent end-stage comorbidity in patients 
undergoing elective surgery when icU ad-
to achieve good calibration the 2014 and 
2015 models included interactions between 
some of the end-stage comorbidities and other 
variables (online supplementary Material 1).
in the mortality models dedicated to patients 
with short length of ICU stay (<24 hours), in-
stead, ceDs only occasionally turned out to be 
significant. Severe COPD was never included in 
the models. NYHa class iV was an independent 
mortality predictor in 2013, dementia in 2014, 
cirrhosis in 2014 and 2015, end-stage renal dis-
eases entered the model with a protective effect 
in 2012 (online supplementary Material 1).
in all prognostic models, age always turned 
out to be an independent predictor of hospital 
mortality.
Table II.—Severity on admission to the ICU and outcome measures in the three subsets object of the study. Patients 
with and without advanced chronic conditions are compared. Absolute numbers are reported followed by percent-
ages in brackets, for continuous variables the use of medians and interquartile ranges is specified. Expected hospi-
tal mortalities are based on the GiViTI prognostic models predictions. Hospital and post-ICU discharge rates are 
calculated accounting for missing values and after post-ICU exclusion criteria application.
elective surgery with planned 
admission (N.=18,201)






















admission for intensive 
treatment
411 (17.9) 2030 (12.8) 335 (51.1) 1900 (40.9) 2184 (61.3) 10,500 (60.0)
acute organ failures on 
admission
1041 (45.5) 5353 (33.6) 445 (67.9) 2648 (57.0) 2824 (79.3) 13,251 (75.8)
acute respiratory failure 368 (16.1) 1700 (10.7) 289 (44.1) 1546 (33.3) 2033 (57.1) 9626 (55)
acute cardiovascular failure 155 (6.8) 726 (4.6) 189 (28.9) 1083 (23.3) 1342 (37.7) 6307 (36.1)
acute renal failure 775 (33.8) 3798 (23.9) 276 (42.1) 1447 (31.2) 2013 (56.5) 8413 (48.1)
saPs ii - median (iQr) 28 (24-35) 25 (22-32) 33 (25-43) 28 (22-38) 46 (37-59) 43 (35-55)
soFa - median (iQr) 3 (2-5) 2 (1-4) 4 (3-7) 3 (2-6) 6 (3-9) 5 (3-8)
complications during the stay 301 (13.6) 1562 (9.2) 145 (22.1) 832 (17.9) 1085 (30.5) 5520 (31.6)
New failures during the stay 127 (5.5) 636 (4) 71 (10.8) 344 (7.4) 516 (14.5) 2489 (14.2)
icU los: survivors - median 
(iQr)
1 (1-2) 1 (1-2) 1 (1-3) 1 (1-2) 2 (1-4) 2 (1-5)
icU los: non-survivors - 
median (iQr)
4.5 (1-10.8) 6 (2-14) 3 (1-9) 2 (1-7) 2 (1-7) 3 (1-9)
H los: survivors - median 
(iQr)
16 (10-25) 15 (10-23) 16 (46631) 15 (9-24) 16 (10-25) 17 (11-29)
H los: non-survivors - median 
(iQr)
20 (11-33.2) 22 (12-38) 15 (8-26) 14 (6-28.5) 10 (4-21) 11 (4-23)
Mortality icU 98 (4.3) 314 (2.0) 107 (16.3) 430 (9.3) 940 (26.4) 3670 (21.0)















rr (95% ci) icU: ceDs yes 
vs. no
2.15 (1.88-2.46) 1.75 (1.39-2.21) 1.26 (1.16-1.36)
rr (95% ci) hospital: ceDs 
yes vs. no
1.79 (1.6-2.0) 1.70 (1.48-2.21) 1.30 (1.24-1.36)
RR: relative risk; 95 CI: 95% confidence interval; LOS: length of stay; H: hospital; ICU: intensive care unit; 95% CI: 95% confidence interval; 
iQr: interquartile range.
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elective surgery, orthopedic interventions were 
the most frequent (43.8%). this result is con-
sistent with the high prevalence of dementia 
in this group, since this condition strikingly 
increases the risk of hip fracture especially in 
the elderly.24
in this subset about one-quarter of icU ad-
missions occurred in the seven days after the 
day of surgery, while about 20% of such de-
layed admissions occurred among those with-
out ceDs. this pattern was more pronounced 
than in the emergency-surgery subset. this 
finding suggests that, especially among pa-
tients with unplanned admissions after elective 
surgery, in many cases postoperative medical 
complications could have been the cause of 
clinical deterioration. We can also suppose that 
CEDs may have had a facilitating influence on 
medical complications.
the presence of ceDs was associated with 
increased mortality in the icU and in the hos-
pital after icU discharge. according to the 
crude mortality relative risks their influence 
appeared larger in elective-surgery patients 
with planned and unplanned admissions (rr 
mission was planned. This finding is consist-
ent with the strong rationale for postoperative 
ventilation of patients with severe coPD, that 
may induce anaesthesiologists to schedule 
postoperative stays in the icU.21
among patients with ceDs with unplanned 
admission to the icU after elective surgery 
or admitted after emergency surgery almost 
half were affected by dementia. although we 
could not find in the literature data compara-
ble with ours, it has been demonstrated an in-
dependent association between dementia and 
postoperative complications on a very large 
cohort of surgical patients 60 years old or old-
er.22 Although this result was not confirmed in 
a study investigating the role of dementia in 
postoperative complications after hip fracture 
surgery, a significant higher rate of ICU admis-
sions was reported.23 Our findings suggest that 
dementia may be a facilitator for medical or 
surgical critical events after elective and emer-
gency surgery leading to postoperative icU 
admissions.
interestingly, in our sample among patients 
with ceDs and unplanned admission after 
Figure 2.—chronic end-stage diseases entering the giViti prognostic models for patients with an icU stay of 24 hours or 
more, from 2011 through 2015. end-stage chronic renal disease is not reported since it never entered the models.
COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; OR: odds ratios; 95%-CI: 95% confi-
dence interval; NS: statistically non-significant.
*interactions between chronic end-stage diseases and other variables were found. in these cases we did not report ors. inter-
actions can be viewed in detail in online supplementary Material 1.
severe coPD (yes vs. no) NYHa class iV (yes vs. no) Dementia (yes vs. no)cirrhosis with portal 
hypertension (yes vs. no)



































































































































































































































































































































































































































































































































Poole cHroNic eND-stage Diseases iN geriatric sUrgical PatieNts
1290 MiNerVa aNestesiologica December 2017
the short-stay models. this is not surprising 
since patients who die shortly after the admis-
sion to the icU usually bear very severe physi-
ologic derangements (e.g. shock, severe acute 
hypoxia, severe acidosis, severe acute renal 
failure) that carry the main prognostic weight. 
in these patients, chronic conditions are less 
likely to be determinant in the outcome. in-
stead, in patients who survive the early acute 
phase (that we arbitrarily indicate as those sur-
viving at least 24 hours) ceDs play a major 
prognostic role.
severe coPD, NYHa class iV, and cirrho-
sis constantly entered the ≥24-hours ICU-stay 
annual models in the five-year study period, 
while dementia turned out to be an important 
predictor in four out of five years. Chronic 
end-stage renal disease never turned out to be 
a predictor in the five years under scrutiny.
our results were consistent with data from 
the literature concerning coPD, chronic heart 
failure, cirrhosis, and dementia,25-28 but con-
flicted with evidence concerning end-stage re-
nal disease.29, 30 However, our models included 
more prognostically important variables and 
should be thus more reliable for explanatory 
purposes than the cited studies.31 actually, 
when a model does not include most causal 
variables it may include some confounders 
that have a predictive but not a causal rela-
tion with the outcome. a model that instead 
includes most causal factors has a higher prob-
ability of accounting adequately for confound-
ing.
a substantial strength of our study is that 
prognostic models were developed annually, 
assessing the constancy of predictors’ effect 
over time. actually, we have developed ten 
models over five years that are consistent in 
indicating the prognostic role of ceDs. in the 
short icU-stay models ceDs were not prog-
nostically relevant, while in the long icU-stay 
models four ceDs were consistently present 
with quantitative prognostic weights that did 
not change significantly over the study period 
(Figure 2). NYHa class iV and cirrhosis with 
portal hypertension were the strongest predic-
tors of death (adjusted odds ratios ranges were 
1.54-1.91 and 1.67-2.29, respectively), while 
1.79 and 1.70), than in the emergency surgery 
subset (rr 1.30). in this high risk-of-death 
subgroup, absolute mortality rates in patients 
with ceD peaked at 44.6%.
However, the adjusted prognostic weight 
of ceDs was explored with our prognostic 
models after adjusting for tenths of impor-
tant confounders. these models are based 
on the overall population of critically ill pa-
tients admitted to the icUs that participate 
to the MargheritaProsaFe project. We ap-
plied the results of these general models to 
the study subsets defined by the combination 
of age ≥75, surgical status (elective surgery 
with planned or unplanned icU admission, 
and emergency surgery), and the presence 
or not of end-stage comorbidities. this is an 
appropriate procedure when goodness of fit 
is proven in the study subsets. actually, the 
giViti assesses the calibration of the mod-
el in all subgroups defined by each variable 
included in the model using the calibration 
belt.15 When miscalibration is found clinical-
ly meaningful interactions are explored and 
tested until the model calibrates well in each 
subgroup. Our models calibrated well in five 
of the six study subsets, in which the results 
of our general model could be applied reli-
ably. the models slightly underpredicted in 
the first decile of the emergency-surgery with 
ceDss subset. this is, however, a statistical 
finding with limited predictive implications. 
actually, the deviation from the bisector was 
quantitatively small and concerned only pa-
tients with expected mortality between 2% 
and 11%.
the giViti strategy is to develop every 
year two models according to the duration 
of the icU stay, less or more than 24 hours. 
the rationale for this choice is that patients 
with short stays are either very seriously ill 
(those who die) or in fair conditions (those 
discharged alive early after their arrival), thus 
prognosis is likely to be determined by differ-
ent variables, or by same variables but with 
different weights, compared to those staying 
longer in the icU. For example, ceDs vari-
ables, which were stably included in the ≥24-
hour icU-stay models, inconstantly entered 
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Key messages
 — icUs frequently admit elderly pa-
tients submitted to surgical procedures.
 — a relevant percentage of these pa-
tients bears chronic endstage diseases and 
has high in-hospital mortality rates.
 — Dementia, chronic hepatic, cardiac, 
and respiratory endstage diseases are strong 
independent predictors of death in the icU.
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SUPPLEMENTARY MATERIALS
appendIx 1.—Prognostic models develop-
ment categorical variables were crossed 
with hospital mortality, and excluded if lead-
ing to poorly represented cells. the linearity 
of the logit in the continuous variables was 
graphically assessed. Variables whose plot 
evidently deviated from the straight line were 
either log-transformed and re-assessed for 
linearity, or categorized. a stepwise selection 
using likelihood ratio test was used to select 
covariates. The final models calibration was 
assessed with the giViti calibration belt and 
test.13, 14 the same methods were used to as-
sess the calibration in subgroups defined by 
the final covariates, to guarantee the unifor-
mity of fit of the model. The area under the 
receiver operating characteristic (roc) 
curve was calculated to assess the discrimina-
tion of the model. Uniformity of fit was tested 
for all the subsets defined by each variable 
that entered the model with the calibration 
belt and test.
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National report for general ICUs - Year 2011
Prognostic models - Adult patients with LOS>=to 24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality°.
Sample used for model development: Patients with LOS>=24 hours from general Italian ICUs.
Sample size: 30615 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -14.75 (-15.42;-14.08) / /
Miscellanea
Age 0.01 (0.00;0.01) 1.01 (1.00;1.01) <0.0001
Body mass Index (BMI) (Underweight vs. Normal) 0.29 (0.15;0.42) 1.33 (1.16;1.53)
<0.0001Body mass Index (BMI) (Overweight vs. Normal) -0.14 (-0.21;-0.07) 0.87 (0.81;0.94)
Body mass Index (BMI) (Obese vs. Normal) -0.22 (-0.30;-0.13) 0.81 (0.74;0.88)
Surgical status (Non surgical vs. Elective surgical) 0.55 (0.38;0.73) / ⇥
Surgical status (Emergency surgical vs. Elective surgical) 0.60 (0.46;0.73) / ⇥
Coming from operating theatre (Yes vs. No) -0.24 (-0.38;-0.11) 0.78 (0.69;0.89) 0.0003
Admitted from other ICU for treatment continuity (Yes vs. No) -0.26 (-0.43;-0.10) 0.77 (0.65;0.90) 0.0012
Stay before ICU (days) (logarithm) 0.29 (0.25;0.33) 1.34 (1.28;1.40) <0.0001
Admitted in hospital the same day of ICU admission (Yes vs. No) 0.15 (0.05;0.25) 1.16 (1.05;1.28) 0.0025
Comorbidities
Severe COPD (Yes vs. No) 0.29 (0.19;0.39) 1.34 (1.20;1.48) <0.0001
Diabetes with insuline treatment (Yes vs. No) 0.23 (0.12;0.33) 1.25 (1.13;1.39) <0.0001
Moderate or severe liver disease (Yes vs. No) 0.51 (0.34;0.68) 1.67 (1.40;1.98) <0.0001
Autoimmune disease (Yes vs. No) 0.32 (0.16;0.49) 1.38 (1.17;1.63) 0.0002
Malignant haematological disease (Yes vs. No) 0.70 (0.51;0.88) 2.01 (1.67;2.41) <0.0001
Restrictive lung disease (Yes vs. No) 0.32 (0.13;0.51) 1.38 (1.14;1.66) 0.0009
NYHA class II-III (Yes vs. None) 0.13 (0.04;0.22) 1.14 (1.05;1.25)
<0.0001
NYHA class IV (Yes vs. None) 0.49 (0.31;0.68) 1.64 (1.36;1.96)
Metastatic cancer (Yes vs. No) 0.75 (0.61;0.89) 2.11 (1.84;2.42) <0.0001
Clinical conditions on admission
ARDS (Yes vs. No) 0.53 (0.35;0.70) 1.70 (1.42;2.02) <0.0001
Ascites (Yes vs. No) 0.67 (0.32;1.03) 1.96 (1.37;2.80) 0.0002
Systemic hypertensive crisis (Yes vs. No) -0.62 (-0.95;-0.29) 0.54 (0.39;0.75) 0.0002
Seizures (Yes vs. No) -0.44 (-0.65;-0.23) 0.64 (0.52;0.79) <0.0001
Spontaneous Subarachnoid haemorrhage (Yes vs. No) 0.48 (0.26;0.71) 1.62 (1.30;2.03) <0.0001
Cerebral artery stroke (Yes vs. No) 0.30 (0.12;0.48) 1.35 (1.13;1.62) 0.0016
Bowel ischaemia (Yes vs. No) 0.41 (0.16;0.65) 1.50 (1.18;1.91) 0.0011
Acute intoxication (Yes vs. No) -1.37 (-1.78;-0.95) 0.26 (0.17;0.39) <0.0001
Pulmonary hypertension (Yes vs. No) 0.52 (0.23;0.82) 1.68 (1.25;2.26) 0.0006
Restrictive lung disease, exacerbation (Yes vs. No) 0.49 (0.20;0.77) 1.63 (1.23;2.16) 0.0008
Left heart failure with pulmonary edema (Yes vs. No) -0.44 (-0.58;-0.30) 0.64 (0.56;0.74) <0.0001
Spontaneous intracerebral bleeding (Yes vs. No) 0.53 (0.30;0.76) / ⇥
Traumatic diffuse brain injury with oedema (Yes vs. No) 0.94 (0.40;1.48) 2.56 (1.50;4.38) 0.0008
Traumatic brain injury (Yes vs. No) -0.13 (-0.36;0.09) / ⇥
Multiple trauma (Yes vs. No) -0.48 (-0.69;-0.28) 0.62 (0.50;0.76) <0.0001
NON-surgical urinary tract infection or Post-surgical urinary tract infection (Yes vs. No) -0.26 (-0.45;-0.06) 0.77 (0.64;0.94) 0.0084
Primary peritonitis (Yes vs. None) 0.62 (0.30;0.94) 1.86 (1.35;2.57)
<0.0001
NON-surgical secondary peritonitis or Tertiary peritonitis (Yes vs. None) 0.32 (0.12;0.53) 1.38 (1.13;1.70)
Infection severity on admission (Infection vs. nessunaInfezione) 1.85 (0.82;2.88) / ⇥
Infection severity on admission (SEVERE SEPSIS vs. No infection) 2.55 (1.45;3.66) / ⇥
Infection severity on admission (SEPTIC SHOCK vs. No infection) 2.58 (1.45;3.71) / ⇥
Organ failures
Physiopathological index (logarithm) 3.27 (3.07;3.48) / ⇥
GCS (3,4 vs. 15) 0.07 (-0.11;0.25) / ⇥
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 15) -0.25 (-0.59;0.09) / ⇥
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 15) 0.09 (-0.09;0.26) / ⇥
GCS (Worsened during first 24 hours vs. Not worsened) 0.60 (0.43;0.77) 1.82 (1.54;2.16)
<0.0001GCS (Worsening not evaluable in neurological patient* vs. Not worsened) 0.32 (-0.03;0.66) 1.37 (0.97;1.93)
GCS (Worsening not evaluable in NON-neurological patient* vs. Not worsened) 0.08 (-0.14;0.30) 1.09 (0.87;1.35)
Metabolic failure (Yes vs. No) 0.29 (0.21;0.37) 1.33 (1.23;1.44) <0.0001
Neurologic failure (Cerebral coma vs. None) 0.17 (0.00;0.34) 1.19 (1.00;1.41)
<0.0001
Neurologic failure (Metabolic coma vs. None) -0.64 (-0.88;-0.40) 0.53 (0.41;0.67)
Neurologic failure (Postanoxic coma vs. None) -0.06 (-0.27;0.14) 0.94 (0.76;1.15)
Neurologic failure (Toxic coma vs. None) -1.22 (-2.11;-0.34) 0.29 (0.12;0.71)
Neurologic failure (Not evaluable in the first 24 hours vs. None) -0.10 (-0.26;0.06) 0.90 (0.77;1.06)
Respiratory failure (Only hypoxic failure or Hypoxic-hypercapnic failure vs. None) 0.29 (0.20;0.39) 1.34 (1.22;1.47)
<0.0001Respiratory failure (Only hypercapnic failure vs. None) 0.12 (-0.02;0.27) 1.13 (0.98;1.31)
Respiratory failure (Intubation for airway maint. vs. None) 0.34 (0.24;0.44) 1.40 (1.28;1.55)
Cardiovascular failure (Without shock vs. None) 0.17 (0.05;0.28) 1.18 (1.05;1.33)
<0.0001
Cardiovascular failure (Cardiogenic shock vs. None) 0.30 (0.18;0.42) 1.35 (1.20;1.53)
Cardiovascular failure (Neurogenic shock vs. None) 0.94 (0.61;1.27) 2.56 (1.84;3.56)
Cardiovascular failure (Other shock vs. None) 0.08 (-0.04;0.20) 1.08 (0.96;1.22)
Cardiovascular failure (Mixed shock vs. None) 0.36 (0.12;0.60) 1.44 (1.13;1.83)
(to be continued)
° For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
See below.
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haemathoma, Traumatic Intraparenchimal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
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Surgical and non surgical procedures
Nephro/Urological surgery (Yes vs. No) -0.57 (-0.82;-0.32) 0.57 (0.44;0.73) <0.0001
Orthopaedic surgery (Yes vs. No) -0.30 (-0.49;-0.11) 0.74 (0.61;0.89) 0.0015
Biliary tract surgery (Yes vs. No) -0.31 (-0.56;-0.05) 0.74 (0.57;0.95) 0.0165
Neurosurgery (Yes vs. No) 2.52 (0.51;4.54) / ⇥
Interventional neuroradiology (Yes vs. No) 3.77 (-0.10;7.63) / ⇥
Interactions among independent variables
Physiopathological index (logarithm)⇥ Interventional neuroradiology -0.97 (-2.04;0.10) / 0.0899
Physiopathological index (logarithm)⇥ Neurosurgery -0.69 (-1.24;-0.15) / 0.0159
Physiopathological index (logarithm)⇥ Infections -0.50 (-0.76;-0.24) / 0.0002
Surgical status (Non surgical)⇥ Infection severity on admission (Infection) -0.18 (-0.60;0.24) /
0.0644
Surgical status (Emergency surgical)⇥Infection severity on admission (Infection) -0.10 (-0.55;0.35) /
Surgical status (Non surgical)⇥Infection severity on admission (SEVERE SEPSIS) -0.67 (-1.23;-0.11) /
Surgical status (Emergency surgical)⇥Infection severity on admission (SEVERE SEPSIS) -0.61 (-1.20;-0.02) /
Surgical status (Non surgical)⇥Infection severity on admission (SEPTIC SHOCK ) -0.65 (-1.22;-0.08) /
Surgical status (Emergency surgical)⇥Infection severity on admission (SEPTIC SHOCK ) -0.73 (-1.31;-0.15) /
GCS (3,4)⇥ Traumatic brain injury 0.89 (0.51;1.26) /
<0.0001GCS (Not evaluable in the first 24 hours in neurological patient*)⇥ Traumatic brain injury 0.11 (-0.24;0.47) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient*)⇥ Traumatic brain injury 0.20 (-1.00;1.39) /
GCS (3,4)⇥ Spontaneous intracerebral bleeding 0.93 (0.53;1.32) /
<0.0001
GCS (Not evaluable in the first 24 hours in neurological patient*)⇥ Spontaneous intracerebral bleeding 0.64 (0.25;1.02) /
Dependent variable explained
Likelihood Ratio Test: 9783
Degree of freedom: 81
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.84
GiViTI Calibration Test: 1.80e-12
p-value: 1
Physiopathological index
The physiopathological index is a rework of SAPSII physiopathological components. It comes from a logistic regeression model and it represents organs and









GCS Not evaluable in the first 24 hours in neurological patient* 15.96
GCS Not evaluable in the first 24 hours in NON-neurological patient* 9.63
Bilirubin (mg/100ml) 4-11.9 5.47
Bilirubin (mg/100ml) >=12 9.57
Heart rate (bpm) <40 1.29
Heart rate (bpm) >=120 2.07
WBC (109/L) <1 4.11
WBC (109/L)>=20 2.45
Serum urea (mg/100 ml) >=60 4.41
Sodium (mEq/L) <125 3.92
Sodium (mEq/L) >=145 2.78
HCO3 (mEq/L) <15 2.63
Platelets (103/mm3) 99-50 3.66
Platelets (103/mm3) 49-20 8.29
Platelets (103/mm3) <20 13.37
Systolic Blood Pressure (mmHg) < 70 5.55
Systolic Blood Pressure (mmHg) 70-99 3.58
Urine Output (L/24h) <0.2 11.20
Urine Output (L/24h) 0.2-0.49 8.02
Urine Output (L/24h) 0.5-0.99 3.95
PaO2/FiO2 (100*mmHg/%) 100-199 3.36
PaO2/FiO2 (100*mmHg/%) <100 7.62
See below.
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haemathoma, Traumatic Intraparenchimal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
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National report for general ICUs - Year 2011
Prognostic models - Adult patients with LOS<24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality°.
Sample used for model development: Patients with LOS<24 hours from general Italian ICUs.
Sample size: 11424 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -7.40 (-7.93;-6.87) / /
Miscellanea
Age 0.04 (0.03;0.04) 1.04 (1.03;1.04) <0.0001
Body mass Index (BMI) (Underweight vs. Normal) 0.39 (0.07;0.71) 1.47 (1.07;2.03)
<0.0001
Body mass Index (BMI) (Overweight or Obese vs. Normal) -0.29 (-0.46;-0.12) 0.75 (0.63;0.89)
Surgical status (Non surgical vs. Elective surgical) 0.68 (0.33;1.04) / ⇥
Surgical status (Emergency surgical vs. Elective surgical) 0.67 (0.41;0.93) / ⇥
Ward of admission (Medical ward vs. Surgical ward) 0.64 (0.32;0.97) 1.91 (1.38;2.63)
0.0006
Ward of admission (Emergency room vs. Surgical ward) 0.51 (0.18;0.84) 1.67 (1.20;2.33)
Ward of admission (Other ICU vs. Surgical ward) 0.66 (0.10;1.22) 1.94 (1.11;3.39)
Ward of admission (High dependency care unit vs. Surgical ward) 1.07 (0.31;1.84) 2.92 (1.36;6.28)
Stay before ICU (days) (logarithm) 0.44 (0.33;0.54) 1.55 (1.40;1.72) <0.0001
Admitted in hospital the same day of ICU admission (Yes vs. No) 0.45 (0.17;0.74) 1.57 (1.18;2.09) 0.0019268
Comorbidities
Peripheral vascular disease (Yes vs. No) 0.34 (0.09;0.58) 1.40 (1.10;1.79) 0.0080
Any tumour without metastasis (Yes vs. None) 0.42 (0.18;0.66) 1.52 (1.20;1.94)
<0.0001
Metastatic cancer (Yes vs. None) 1.07 (0.80;1.35) 2.92 (2.22;3.85)
Clinical conditions on admission
Acute intoxication (Yes vs. No) -2.20 (-3.41;-1.00) 0.11 (0.03;0.37) <0.0001
Spontaneous intracerebral bleeding (Yes vs. No) 0.64 (0.19;1.09) 1.90 (1.20;2.99) 0.0062
Left heart failure with pulmonary edema (Yes vs. No) -0.77 (-1.21;-0.33) 0.46 (0.30;0.72) 0.0006
Organ failures
GCS (3,4 vs. 13,14,15) 2.99 (2.58;3.40) 19.84 (13.19;29.85)
<0.0001
GCS (5 vs. 13,14,15) 1.49 (0.66;2.32) 4.43 (1.93;10.13)
GCS (6 vs. 13,14,15) 1.20 (0.52;1.88) 3.32 (1.68;6.58)
GCS (7,8 vs. 13,14,15) 0.83 (0.35;1.30) 2.28 (1.42;3.66)
GCS (9,10,11,12 vs. 13,14,15) 0.53 (0.24;0.83) 1.71 (1.27;2.28)
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 13,14,15) 0.29 (-0.34;0.93) 1.34 (0.71;2.54)
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 13,14,15) 0.37 (-0.12;0.85) 1.44 (0.89;2.34)
Bilirubin (mg/100ml) (4-11.9 vs. <4) 0.75 (0.22;1.28) 2.12 (1.24;3.61)
0.0216
Bilirubin (mg/100ml) (>=12 vs. <4) 0.43 (-0.72;1.59) 1.54 (0.49;4.89)
Heart rate (bpm) (<40 vs. 40-120) 0.78 (0.39;1.16) 2.17 (1.48;3.19)
0.0003
Heart rate (bpm) (>=120 vs. 40-120) 0.21 (-0.05;0.46) 1.23 (0.95;1.58)
HCO3 (mEq/L) (<15 vs. >=15) 0.51 (0.18;0.83) 1.66 (1.20;2.30) 0.0023
Platelets (103 /mm3) (99-50 vs. >=100) 0.43 (0.09;0.77) 1.54 (1.10;2.16)
0.0058Platelets (103 /mm3) (49-20 vs. >=100) 0.69 (0.15;1.24) 2.00 (1.16;3.44)
Platelets (103 /mm3) (<20 vs. >=100) 0.67 (-0.31;1.66) 1.96 (0.73;5.25)
Systolic Blood Pressure (mmHg) (<70 vs. >=100) 1.34 (1.03;1.66) 3.83 (2.80;5.25)
<0.0001
Systolic Blood Pressure (mmHg) (70-99 vs. >=100) 0.54 (0.34;0.74) 1.72 (1.40;2.11)
Urine Output (L/24h) (<0.2 vs. >=1) 1.54 (1.23;1.86) 4.68 (3.41;6.41)
<0.0001Urine Output (L/24h) (0.2-0.49 vs. >=1) 1.41 (1.07;1.75) 4.10 (2.93;5.74)
Urine Output (L/24h) (0.5-0.99 vs. >=1) 0.52 (0.30;0.74) 1.68 (1.35;2.09)
PaO2/FiO2 (100*mmHg/%)(100-199 vs. >=200) 0.44 (0.20;0.68) 1.55 (1.23;1.97)
<0.0001
PaO2/FiO2 (100*mmHg/%)(<100 vs. >=200) 0.94 (0.51;1.36) 2.56 (1.67;3.91)
Cardiovascular failure (Without shock vs. None) 0.71 (0.27;1.15) 2.03 (1.31;3.15)
<0.0001
Cardiovascular failure (Cardiogenic shock vs. None) 1.20 (0.81;1.60) 3.34 (2.24;4.96)
Cardiovascular failure (Septic shock vs. None) 1.11 (0.59;1.62) 3.03 (1.81;5.08)
Cardiovascular failure (Haemorrhagic/hypovolemic shock vs. None) 1.17 (0.74;1.60) 3.21 (2.09;4.94)
Cardiovascular failure (Hypovolemic shock vs. None) 0.45 (-0.23;1.13) 1.57 (0.79;3.11)
Cardiovascular failure (Neurogenic shock vs. None) 2.22 (1.13;3.31) 9.18 (3.09;27.29)
Cardiovascular failure (Other shock vs. None) 1.62 (0.75;2.49) 5.06 (2.12;12.09)
Cardiovascular failure (Mixed shock vs. None) 1.87 (0.87;2.87) 6.49 (2.38;17.67)
Respiratory failure (Only hypoxic failure vs. None) 0.49 (0.17;0.80) 1.63 (1.19;2.23)
0.0014
Respiratory failure (Only hypercapnic failure vs. None) -0.04 (-0.58;0.50) 0.96 (0.56;1.65)
Respiratory failure (Hypoxic-hypercapnic failure vs. None) 0.75 (0.32;1.19) 2.12 (1.37;3.28)
Respiratory failure (Intubation for airway maint. vs. None) 0.31 (0.05;0.57) 1.36 (1.05;1.78)
Metabolic failure (Yes vs. No) 0.50 (0.26;0.74) 1.65 (1.30;2.10) <0.0001
Surgical and non surgical procedures
Gastrointestinal surgery (Yes vs. No) 0.36 (0.12;0.60) 1.43 (1.13;1.82) 0.0036
Neurosurgery (Yes vs. No) 0.71 (0.32;1.10) 2.04 (1.38;3.02) 0.0006
Interventional cardiology (Yes vs. No) -1.26 (-1.84;-0.67) 0.29 (0.16;0.51) <0.0001
Interactions among independent variables
Surgical status (Non surgical)⇥ GCS Not evaluable in the first 24 hours 1.31 (0.72;1.91) /
<0.0001
Surgical status (Emergency surgical)⇥ GCS Not evaluable in the first 24 hours 0.78 (0.15;1.41) /
Dependent variable explained
Likelihood ratio test: 7586
Degree of freedom: 58
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.95
GiViTI Calibration Test: 4.08e-13
p-value: 1
° For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haemathoma, Traumatic Intraparenchimal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
PROSAFE project
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National report for general ICUs - Year 2012
Prognostic models - Adult patients with LOS>=to 24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality◦.
Sample used for model development: Patients with LOS>=24 hours from general Italian ICUs.
Sample size: 34225 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -7.11 (-7.6;-6.63) / /
Miscellanea
Age <=37 1.49 (1.25;1.73) /
<0.001Age in decades (continuous, 38-79) 0.40 (0.34;0.47) /
Age in decades (continuous, >80) 0.43 (0.37;0.49) /
Body mass Index (BMI) (Underweight vs. Normal) 0.38 (0.25;0.52) 1.47 (1.29;1.67)
<0.001
Body mass Index (BMI) (Overweight or Obese vs. Normal) -0.16 (-0.22;-0.09) 0.86 (0.8;0.91)
Surgical status (Non surgical vs. Elective surgical) 0.86 (0.73;1) / ⇥
Surgical status (Emergency surgical vs. Elective surgical) 0.56 (0.43;0.7) /
Stay before ICU (days) (logarithm) 0.26 (0.22;0.3) 1.3 (1.25;1.36) <0.001
Admitted in hospital the same day of ICU admission (Yes vs. No) 0.19 (0.09;0.29) 1.21 (1.1;1.34) <0.001
Reason for admission (Intensive Treatment vs. Monitoring/Weaning) 0.8 (0.32;1.28) / ⇥
Ward of admission: Medical ward 0.2 (0.12;0.28) 1.22 (1.13;1.33) <0.001
Physiopatological components
Bilirubin (mg/100ml) (4-11.9 vs. <4) 0.45 (0.27;0.64) 1.57 (1.31;1.89)
<0.001
Bilirubin (mg/100ml) (>=12 vs. <4) 1.13 (0.71;1.54) 3.09 (2.04;4.67)
Sodium (mEq/L) (>=145 vs. <145) 0.19 (0.11;0.28) 1.21 (1.11;1.32) <0.001
Platelets (103 /mm3) (50-99 vs. >100) 0.32 (0.22;0.43) 1.38 (1.25;1.53)
<0.001
Platelets (103 /mm3) (<50 vs. >100) 0.72 (0.57;0.86) 2.05 (1.77;2.37)
MAP (mmHg) (<70 vs. >70) 0.4 (0.31;0.48) / ⇥
Urine Output (L/24h) (<0.2 vs. >1) 0.8 (0.65;0.94) 2.21 (1.91;2.56)
<0.001Urine Output (L/24h) (0.2-0.49 vs. >1) 0.47 (0.32;0.61) 1.59 (1.38;1.84)
Urine Output (L/24h) (0.5-0.99 vs. >1) 0.3 (0.21;0.39) 1.35 (1.23;1.48)
WBC (109 /L) (<1 vs. 1-20) 0.47 (0.24;0.69) 1.59 (1.27;2)
<0.001
WBC (109 /L) (>20 vs. 1-20) 0.18 (0.1;0.26) 1.2 (1.1;1.3)
Serum urea (mg/100 ml) (>=60 vs. <60) 0.26 (0.18;0.34) / ⇥
PaO2/FiO2 (100*mmHg/%) (200-299 vs. >=300) 0.11 (0.02;0.2) /
⇥PaO2/FiO2 (100*mmHg/%) (100-199 vs. >=300) 0.26 (0.17;0.35) /
PaO2/FiO2 (100*mmHg/%) (<100 vs. >=300) 0.69 (0.55;0.84) /
Heart rate (bpm) (>=120 vs. <120) 0.24 (0.16;0.32) 1.27 (1.18;1.37) <0.001
Clinical conditions on admission
Acute intoxication (Yes vs. No) -0.98 (-1.32;-0.64) 0.38 (0.27;0.53) <0.001
Spontaneous Intraparenchymal bleeding (Yes vs. No) 0.51 (0.33;0.7) / ⇥
ALI (Acute Lung Injury) (Yes vs. No) 0.15 (0;0.3) 1.16 (1;1.36)
<0.001
ARDS (Yes vs. No) 0.45 (0.25;0.64) 1.56 (1.28;1.9)
Haematological disease (Yes vs. No) 0.58 (0.25;0.9) 1.78 (1.28;2.47) <0.001
Ascites (Yes vs. No) 0.49 (0.16;0.82) 1.63 (1.17;2.27) 0.004
Nephrourologic disease (Yes vs. No) -0.26 (-0.42;-0.11) 0.77 (0.66;0.9) <0.001
Lung cancer (Yes vs. No) 0.81 (0.52;1.09) 2.24 (1.69;2.97) <0.001
Acute pancreatitis (Yes vs. No) 0.56 (0.29;0.83) 1.75 (1.33;2.29) <0.001
Seizures (Yes vs. No) -0.53 (-0.73;-0.32) 0.59 (0.48;0.72) <0.001
Bowel ischaemia (Yes vs. No) 0.43 (0.2;0.66) 1.54 (1.22;1.94) <0.001
Spontaneous Subarachnoid haemorrhage (Yes vs. No) 0.37 (0.14;0.59) 1.44 (1.15;1.8) 0.001
Systemic hypertensive crisis (Yes vs. No) -0.44 (-0.76;-0.11) 0.65 (0.47;0.89) 0.007
Intracranial hypertension (Yes vs. No) 0.77 (0.19;1.34) 2.15 (1.21;3.81) 0.009
Gastrointestinal perforation (Yes vs. No) 0.22 (0.05;0.39) 1.25 (1.05;1.47) 0.010
Pneumonia (Yes vs. No) 0.23 (0.11;0.35) 1.26 (1.12;1.42) <0.001
Peritonites (Yes vs. No) 0.34 (0.15;0.53) 1.41 (1.16;1.7) <0.001
Infection severity on admission (Infection with or without SIRS vs. None) 0.3 (-0.09;0.69) /
⇥Infection severity on admission (SEVERE SEPSIS vs. None) 1.08 (0.59;1.58) /
Infection severity on admission (SEPTIC SHOCK vs. None) 0.88 (0.35;1.4) /
Urinary tract infection (Yes vs. No) -0.22 (-0.46;0.01) / ⇥
Skin or soft tissue infection (Yes vs. No) 0.5 (0.26;0.73) 1.65 (1.3;2.08) <0.001
Trauma(Yes vs. No) -1.23 (-1.79;-0.66) / ⇥
Multiple trauma (Yes vs. No) -0.26 (-0.49;-0.04) 0.77 (0.61;0.96) 0.020
Traumatic brain injury (Yes vs. No) 0.03 (-0.21;0.27) / ⇥
Spinal cord injury with complete neurologic deficit (Yes vs. No) 0.98 (0.35;1.6) 2.65 (1.42;4.97) 0.003
Traumatic diffuse injury with oedema (Yes vs. No) 0.68 (0.14;1.22) 1.98 (1.15;3.39) 0.015
Comorbidities
Any tumour without metastasis (Yes vs. No tumor) 0.78 (0.12;1.45) / ⇥
Metastatic cancer (Yes vs. No tumor) 3.04 (2.24;3.84) /
NYHA class II-III (Yes vs. None) 0.09 (0.01;0.18) 1.1 (1.01;1.2)
<0.001
NYHA class IV (Yes vs. None) 0.43 (0.25;0.61) 1.54 (1.29;1.84)
Malignant haematological disease (Yes vs. No) 0.72 (0.52;0.92) 2.05 (1.68;2.51) <0.001
Moderate or severe liver disease (Yes vs. No) 0.68 (0.5;0.85) 1.97 (1.64;2.35) <0.001
Severe COPD (Yes vs. No) 0.36 (0.26;0.46) 1.44 (1.3;1.59) <0.001
Diabetes with insuline treatment (Yes vs. No) 0.23 (0.13;0.32) 1.25 (1.14;1.38) <0.001
Severe malnutrition (Yes vs. No) 1.89 (0.83;2.95) / ⇥
Renal failure (Yes vs. No) 0.13 (0.04;0.23) 1.14 (1.04;1.26) 0.006
Dementia (Yes vs. No) 0.24 (0.11;0.38) 1.28 (1.11;1.46) <0.001
Hemiplegia or paraplegia or quadriplegia (Yes vs. No) 0.27 (0.12;0.42) 1.31 (1.12;1.52) <0.001
Immunosuppression (Yes vs. No) 0.28 (0.08;0.48) 1.32 (1.09;1.61) 0.005
Restrictive lung disease (Yes vs. No) 1.82 (0.95;2.69) / ⇥
Arrhythmia (Yes vs. No) 0.09 (0.02;0.17) 1.1 (1.02;1.18) 0.017
(to be continued)
◦ For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
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Organ failures
GCS (3,4 vs. 15) 2.14 (1.88;2.4) /
⇥
GCS (5 vs. 15) 1.71 (1.39;2.03) /
GCS (6 vs. 15) 0.91 (0.68;1.14) /
GCS (7,8,9,10 vs. 15) 0.5 (0.38;0.62) /
GCS (11,12,13,14 vs. 15) 0.31 (0.22;0.4) /
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 15) 1.59 (1.35;1.83) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 15) 0.67 (0.57;0.76) /
Neurologic failure (Cerebral coma vs. None or Not evaluable in the first 24 hours) 0.38 (0.22;0.54) 1.46 (1.24;1.71)
<0.001
Neurologic failure (Metabolic coma vs. None or Not evaluable in the first 24 hours) -0.29 (-0.48;-0.11) 0.75 (0.62;0.9)
Neurologic failure (Postanoxic coma vs. None or Not evaluable in the first 24 hours) 0.94 (0.25;1.63) 2.56 (1.28;5.11)
Neurologic failure (Toxic coma vs. None or Not evaluable in the first 24 hours) -0.78 (-1.32;-0.23) 0.46 (0.27;0.79)
Cardiovascular failure (Cardiogenic shock vs. None or Without shock) 0.45 (0.32;0.57) 1.56 (1.38;1.76)
<0.001
Cardiovascular failure (Neurogenic shock vs. None or Without shock) 0.86 (0.54;1.18) 2.37 (1.72;3.26)
Cardiovascular failure (Haemorrhagic/hypovolemic shock vs. None or Without shock) 0.23 (0.08;0.39) 1.26 (1.08;1.47)
Cardiovascular failure (Other shock vs. None or Without shock) 0.08 (-0.07;0.24) 1.09 (0.93;1.27)
Cardiovascular failure (Mixed shock vs. None or Without shock) 0.3 (0.05;0.55) 1.35 (1.05;1.74)
Renal failure (AKIN) (Mild vs. None) 0.06 (-0.03;0.15) / ⇥
Renal failure (AKIN) (Moderate or Severe vs. None) 0.44 (0.31;0.56) /
Respiratory failure (Yes vs. No) 0.21 (0.08;0.35) 1.24 (1.08;1.42) 0.002
Metabolic failure (Yes vs. No) 0.18 (0.1;0.25) 1.19 (1.11;1.29) <0.001
Surgical and non surgical procedures
Gastrointestinal surgery (Yes vs. No) 0.31 (0.2;0.43) 1.37 (1.22;1.54) <0.001
Pancreatic surgery (Yes vs. No) 0.79 (0.5;1.08) 2.2 (1.64;2.95) <0.001
Organ/s transplantation (Yes vs. No) -1.84 (-2.63;-1.04) 0.16 (0.07;0.35) <0.001
Interventional cardiology (Yes vs. No) -0.33 (-0.52;-0.14) 0.72 (0.59;0.87) <0.001
Interactions among independent variables
GCS (3,4)⇥ Serum urea (mg/100 ml) (>=60) -0.26 (-0.49;-0.04) /
0.006GCS (5)⇥ Serum urea (mg/100 ml) (>=60) -0.5 (-0.95;-0.06) /
GCS Not evaluable in the first 24 hours in neurological patient*⇥ Serum urea (mg/100 ml) (>=60) -0.29 (-0.58;-0.01) /
GCS (3,4)⇥ Infections -0.81 (-1.07;-0.54) /
<0.001
GCS Not evaluable in the first 24 hours in neurological patient*⇥ Infections -0.39 (-0.74;-0.04) /
MAP (mmHg) (<70)⇥ Infections -0.3 (-0.44;-0.16) / <0.001
GCS (3,4)⇥ Spontaneous Intraparenchymal bleeding 0.99 (0.61;1.36) / <0.001
GCS (3,4)⇥ Traumatic brain injury 0.85 (0.45;1.24) /
<0.001GCS (5)⇥ Traumatic brain injury 0.13 (-0.51;0.77) /
GCS (6)⇥ Traumatic brain injury 0.82 (0.26;1.39) /
Surgical status (Non surgical)⇥ Infection severity on admission Infection with or without SIRS -0.34 (-0.74;0.06) /
<0.001
Surgical status (Emergency surgical)⇥ Infection severity on admission Infection with or without SIRS -0.42 (-0.87;0.02) /
Surgical status (Non surgical)⇥ Infection severity on admission SEVERE SEPSIS -0.88 (-1.39;-0.38) /
Surgical status (Emergency surgical)⇥ Infection severity on admission SEVERE SEPSIS -1.06 (-1.59;-0.53) /
Surgical status (Non surgical)⇥ Infection severity on admission SEPTIC SHOCK -0.71 (-1.22;-0.2) /
Surgical status (Emergency surgical)⇥ Infection severity on admission SEPTIC SHOCK -0.71 (-1.22;-0.19) /
Urinary tract infection⇥ Renal failure (AKIN) (Moderate or Severe) -0.51 (-0.85;-0.17) / 0.003
Age ⇥ Trauma 0.02 (0.01;0.02) / <0.001
Age ⇥ Any tumour without metastasis -0.01 (-0.02;0) /
<0.001
Age ⇥ Metastatic cancer -0.03 (-0.04;-0.02) /
Age ⇥ Severe malnutrition -0.02 (-0.04;0) / 0.012
Age ⇥ Restrictive lung disease -0.02 (-0.03;-0.01) / 0.002
Age ⇥ Neurologic failure (Postanoxic coma) -0.01 (-0.02;0) / 0.078
Age ⇥ Reason for admission (Intensive Treatment) -0.01 (-0.01;0) / 0.016
GCS (3,4)⇥ PaO2/FiO2 (100*mmHg/%) (200-299) -0.07 (-0.33;0.19) /
0.020
GCS (3,4)⇥ PaO2/FiO2 (100*mmHg/%) (100-199) -0.37 (-0.65;-0.1) /
GCS (3,4)⇥ PaO2/FiO2 (100*mmHg/%) (<100) -0.34 (-0.79;0.12) /
GCS Not evaluable in the first 24 hours in neurological patient*⇥ PaO2/FiO2 (100*mmHg/%) (200-299) 0.09 (-0.19;0.38) /
GCS Not evaluable in the first 24 hours in neurological patient*⇥ PaO2/FiO2 (100*mmHg/%) (100-199) 0 (-0.35;0.35) /
GCS Not evaluable in the first 24 hours in neurological patient*⇥ PaO2/FiO2 (100*mmHg/%) (<100) -0.92 (-1.72;-0.12) /
Dependent variable explained
Likelihood Ratio Test: 11382
Degree of freedom: 122
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.848
GiViTI Calibration Test: 0
p-value: 1
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haemathoma, Traumatic Intraparenchimal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
The age used in interactions is the maximum between the age and 37.
⇥ See interaction significance.
PROSAFE project
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National report for general ICUs - Year 2012
Prognostic models - Adult patients with LOS<24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality◦.
Sample used for model development: Patients with LOS<24 hours from general Italian ICUs.
Sample size: 12746 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -7.02 (-7.51;-6.52) / /
Miscellanea
Age in decades 0.37 (0.31;0.43) 1.45 (1.37;1.53) <0.001
Body mass Index (BMI) (Underweight vs. Normal) 0.33 (0.02;0.64) 1.39 (1.02;1.9)
<0.001
Body mass Index (BMI) (Overweight or Obese vs. Normal) -0.41 (-0.57;-0.24) 0.67 (0.56;0.79)
Surgical status (Non surgical vs. Elective surgical) 0.42 (0.16;0.69) 1.53 (1.17;1.99)
<0.001
Surgical status (Emergency surgical vs. Elective surgical) 0.44 (0.21;0.67) 1.55 (1.23;1.96)
Stay before ICU (days) (logarithm) 0.36 (0.26;0.46) 1.43 (1.29;1.59) <0.001
Admitted in hospital the same day of ICU admission (Yes vs. No) 0.42 (0.17;0.68) 1.53 (1.18;1.97) 0.001
Reason for admission (Intensive Treatment vs. Monitoring/Weaning) -0.52 (-1.01;-0.03) / ⇥
Ward of admission: formato("admWard","medicalWard") 0.5 (0.24;0.75) 1.64 (1.27;2.11) <0.001
Physiopatological components
Bilirubin (mg/100ml) (>=4 vs. <4) 0.79 (0.33;1.25) 2.21 (1.4;3.5) 0.001
Heart rate (bpm) (<40 vs. >=40) 0.87 (0.42;1.31) 2.38 (1.52;3.71) <0.001
WBC (109 /L) (>20 vs. <=20) 0.44 (0.17;0.71) 1.55 (1.18;2.03) 0.002
HCO3 (mEq/L) (<15 vs. >20) 0.73 (0.38;1.08) 2.07 (1.47;2.93)
<0.001
HCO3 (mEq/L) (15-20 vs. >20) 0.23 (0.03;0.44) 1.26 (1.03;1.55)
Platelets (103 /mm3) (50-99 vs. >100) 0.31 (-0.01;0.63) 1.37 (0.99;1.88)
<0.001
Platelets (103 /mm3) (<50 vs. >100) 1.02 (0.54;1.5) 2.77 (1.72;4.48)
Systolic Blood Pressure (mmHg) (<70 vs. >=100) 1.08 (0.7;1.47) / ⇥
Systolic Blood Pressure (mmHg) (70-99 vs. >=100 ) 0.35 (0.13;0.57) /
Urine Output (L/24h) (<0.49 vs. >=1) 1.06 (0.63;1.49) / ⇥
Urine Output (L/24h) (0.5-0.99 vs. >=1) 0.41 (0.17;0.65) /
PaO2/FiO2 (100*mmHg/%) (100-199 vs. >=200) 0.31 (0.1;0.53) 1.36 (1.1;1.69)
<0.001
PaO2/FiO2 (100*mmHg/%) (<100 vs. >=200) 1.46 (1.02;1.9) 4.3 (2.76;6.69)
Clinical conditions on admission
Spontaneous Intraparenchymal bleeding (Yes vs. No) 1.56 (1.08;2.03) 4.76 (2.96;7.65) <0.001
Nephrourologic disease (Yes vs. No) -0.57 (-0.93;-0.21) 0.57 (0.39;0.81) <0.001
Bowel ischaemia (Yes vs. No) 0.98 (0.31;1.65) / ⇥
Spontaneous Subarachnoid haemorrhage (Yes vs. No) 1.37 (0.79;1.95) 3.93 (2.2;7.04) <0.001
Pulmonary embolism (Yes vs. No) 1.37 (0.69;2.06) 3.95 (1.99;7.85) <0.001
Ruptured or fissured aneurysm (Yes vs. No) 1.05 (0.43;1.66) 2.85 (1.54;5.29) 0.001
Traumatic brain injury (Yes vs. No) 0.95 (0.53;1.38) 2.6 (1.7;3.97) <0.001
Peritonites (Yes vs. No) 0.74 (0.21;1.26) 2.09 (1.24;3.53) 0.006
Infections (Yes vs. No) 0.39 (0.06;0.71) 1.47 (1.06;2.04) 0.022
Comorbidities
Metastatic cancer (Yes vs. No) 0.79 (0.53;1.05) 2.2 (1.69;2.85) <0.001
Restrictive lung disease (Yes vs. No) 0.94 (0.51;1.37) 2.56 (1.66;3.93) <0.001
End-stage renal disease (Yes vs. No) -0.93 (-1.48;-0.39) 0.39 (0.23;0.68) <0.001
Diabetes with insuline treatment (Yes vs. No) 0.39 (0.12;0.65) 1.47 (1.13;1.92) 0.005
Malignant haematological disease (Yes vs. No) 0.73 (0.22;1.25) 2.08 (1.24;3.49) 0.007
Organ failures
GCS (3 vs. 15) 2.86 (2.45;3.28) /
⇥
GCS (4,5 vs. 15) 2.13 (1.59;2.67) /
GCS (6,7,8 vs. 15) 0.24 (-0.42;0.9) /
GCS (9,10,11,12,13,14 vs. 15) 0.66 (0.45;0.87) /
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 15) 1.08 (0.64;1.51) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 15) 0.6 (0.28;0.93) /
Cardiovascular failure (Without shock vs. None) 0.52 (0.06;0.97) 1.68 (1.07;2.64)
<0.001
Cardiovascular failure (Cardiogenic shock vs. None) 0.94 (0.55;1.34) 2.57 (1.73;3.81)
Cardiovascular failure (Septic shock vs. None) 1 (0.34;1.67) 2.73 (1.4;5.32)
Cardiovascular failure (Haemorrhagic/hypovolemic shock vs. None) 0.67 (0.16;1.18) 1.96 (1.18;3.27)
Cardiovascular failure (Hypovolemic shock vs. None) -0.07 (-0.81;0.66) 0.93 (0.45;1.94)
Cardiovascular failure (Neurogenic shock vs. None) 2.07 (1.07;3.08) 7.96 (2.92;21.69)
Cardiovascular failure (Other shock vs. None) 1.33 (0.56;2.1) 3.79 (1.75;8.19)
Cardiovascular failure (Mixed shock vs. None) 1.52 (0.42;2.63) 4.59 (1.52;13.82)
Respiratory failure (Yes vs. No) 0.95 (0.5;1.4) 2.59 (1.66;4.06) <0.001
Renal failure (AKIN) (Mild vs. None) 0.4 (0.17;0.63) 1.49 (1.19;1.87)
<0.001
Renal failure (AKIN) (Moderate or Severe 0.64 (0.31;0.98) 1.9 (1.36;2.66)
Interactions among independent variables
GCS (6,7,8)⇥ Systolic Blood Pressure (mmHg) (<70) 1.76 (0.42;3.1) /
<0.001
GCS (6,7,8)⇥ Systolic Blood Pressure (mmHg) (70-99) 1.08 (0.07;2.08) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient*)⇥ Systolic Blood Pressure (mmHg) (<70) 1.14 (0.39;1.89) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient*)⇥ Systolic Blood Pressure (mmHg) (70-99) 0.57 (0.03;1.11) /
Systolic Blood Pressure (mmHg) (<70)⇥ Urine Output (L/24h) (<0.49 vs. >=1) 1.13 (0.45;1.8) /
0.001
Systolic Blood Pressure (mmHg) (70-99)⇥ Urine Output (L/24h) (<0.49 vs. >=1) 0.69 (0.15;1.23) /
Bowel ischaemia⇥ Reason for admission (Intensive Treatment) 1.32 (-0.21;2.85) / 0.071
Dependent variable explained
Likelihood ratio test: 8558.6
Degree of freedom: 60
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.954
GiViTI Calibration Test: 0
p-value: 1
◦ For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haemathoma, Traumatic Intraparenchimal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
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National report for general ICUs - Year 2013
Prognostic models - Adult patients with LOS>=to 24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality°.
Sample used for model development: Patients with LOS>=24 hours from general Italian ICUs.
Sample size: 35612 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -6.36 (-6.69;-6.04) / /
Miscellanea
Age in decades (continuous, <40) 0.432 (0.342;0.521) /
<0.001Age in decades (continuous, 40-80) 0.377 (0.338;0.416) /
Age in decades (continuous, >80) 0.401 (0.367;0.435) /
Body mass Index (BMI) (Underweight vs. Normal) 0.15 (0.02;0.28) 1.16 (1.02;1.32)
<0.001
Body mass Index (BMI) (Overweight or Obese vs. Normal) -0.19 (-0.25;-0.13) 0.83 (0.78;0.88)
Surgical status (Non surgical vs. Elective surgical) 0.5 (0.34;0.66) / ⇥
Surgical status (Emergency surgical vs. Elective surgical) 0.34 (0.22;0.46) /
Stay before ICU (days) (logarithm, if <28 days) 0.31 (0.26;0.36) /
⇥Stay before ICU (days) (>28 vs. <=28) 3.04 (2.24;3.85) /
Admitted in hospital the same day of ICU admission (Yes vs. No) 0.27 (0.16;0.37) /
Ward of admission: Medical ward vs. Surgical ward 0.15 (0.04;0.26) /
⇥
Ward of admission: Emergency room vs. Surgical ward -0.28 (-0.42;-0.14) /
Ward of admission: High dependency care unit vs. Surgical ward 0.22 (0.04;0.39) /
Ward of admission: Other ICU because of Specialist expertise vs. Surgical ward -0.1 (-0.34;0.14) /
Ward of admission: Other ICU because of Step-up care vs. Surgical ward 0.3 (0;0.6) /
Ward of admission: Other ICU because of Logistical/organizational reasons vs. Surgical ward -0.24 (-0.41;-0.06) /
Ward of admission: Long-term chronic care hospital vs. Surgical ward 0.3 (-0.07;0.66) /
Operating theatre (Yes vs. No) -0.32 (-0.45;-0.19) 0.73 (0.64;0.83) <0.001
Physiopatological components
Bilirubin (mg/100ml) (1.2-3.9 vs. <1.2) 0.15 (0.07;0.22) 1.16 (1.07;1.25)
<0.001Bilirubin (mg/100ml) (4-11.9 vs. <1.2) 0.35 (0.17;0.53) 1.42 (1.18;1.7)
Bilirubin (mg/100ml) (>=12 vs. <1.2) 0.52 (0.14;0.89) 1.68 (1.15;2.43)
Sodium (mEq/L) (>=145 vs. <145) 0.28 (0.19;0.37) / ⇥
Platelets (103 /mm3) (50-99 vs. >=100) 0.23 (0.13;0.33) /
⇥Platelets (103 /mm3) (20-49 vs. >=100) 0.57 (0.41;0.74) /
Platelets (103 /mm3) (<20 vs. >=100) 0.73 (0.45;1.01) /
Urine Output (L/24h) (<0.2 vs. >=1) 0.73 (0.54;0.92) /
⇥Urine Output (L/24h) (0.2-0.49 vs. >=1) 0.43 (0.28;0.59) /
Urine Output (L/24h) (0.5-0.99 vs. >=1) 0.21 (0.12;0.3) /
WBC (109 /L) (<1 vs. 1-20) 0.35 (0.15;0.56) 1.42 (1.16;1.75)
<0.001
WBC (109 /L) (>20 vs. 1-20) 0.15 (0.07;0.24) 1.17 (1.07;1.27)
Serum urea (mg/100 ml) (60-179 vs. <60) 0.19 (0.12;0.27) / ⇥
Serum urea (mg/100 ml) (>=180 vs. <60) 0.51 (0.34;0.69) /
PaO2/FiO2 (100*mmHg/%) (200-299 vs. >=300) 0.2 (0.12;0.28) /
⇥PaO2/FiO2 (100*mmHg/%) (100-199 vs. >=300) 0.36 (0.27;0.45) /
PaO2/FiO2 (100*mmHg/%) (<100 vs. >=300) 0.78 (0.63;0.92) /
Heart rate (bpm) (<70 vs. 70-119) -0.24 (-0.33;-0.15) / ⇥
Heart rate (bpm) (>=120 vs. 70-119) 0.1 (0.02;0.18) /
Systolic Blood Pressure (mmHg) (<70 vs. >=100) 0.51 (0.41;0.62) 1.67 (1.51;1.86)
<0.001
Systolic Blood Pressure (mmHg) (70-99 vs. >=100) 0.19 (0.12;0.26) 1.21 (1.13;1.3)
Potassium (mEq/L) (<3 vs. 3-4.9) 0.21 (0.08;0.33) 1.23 (1.08;1.39)
0.001
Potassium (mEq/L) (>=5 vs. 3-4.9) 0.1 (0.01;0.19) 1.1 (1.01;1.21)
Clinical conditions on admission
Acute intoxication (Yes vs. No) -0.89 (-1.22;-0.56) 0.41 (0.3;0.57) <0.001
Spontaneous Intraparenchymal bleeding (Yes vs. No) 0.72 (0.51;0.93) / ⇥
ARDS (Moderate or Severe vs. No or Mild) 0.25 (0.09;0.41) 1.29 (1.09;1.51) 0.002
Haematological disease (Yes vs. No) 0.54 (0.21;0.88) 1.72 (1.23;2.4) 0.002
Ascites (Yes vs. No) 0.47 (0.13;0.81) 1.6 (1.14;2.25) 0.007
Lung cancer (Yes vs. No) 0.88 (0.61;1.15) 2.41 (1.84;3.15) <0.001
Acute pancreatitis (Yes vs. No) 0.49 (0.24;0.74) 1.64 (1.28;2.1) <0.001
Seizures (Yes vs. No) -0.33 (-0.52;-0.13) 0.72 (0.6;0.88) 0.001
Bowel ischaemia (Yes vs. No) 0.66 (0.43;0.89) 1.94 (1.54;2.43) <0.001
Spontaneous Subarachnoid haemorrhage (Yes vs. No) 0.61 (0.4;0.83) 1.85 (1.49;2.29) 0.001
Gastrointestinal perforation (Yes vs. No) 0.47 (0.31;0.63) 1.6 (1.36;1.88) <0.001
Cardiac arrest (Yes vs. No) 0.31 (0.16;0.45) 1.36 (1.17;1.57) <0.001
Cerebral artery stroke (Yes vs. No) 0.29 (0.12;0.46) 1.34 (1.13;1.59) <0.001
Left heart failure with pulmonary edema (Yes vs. No) -0.28 (-0.41;-0.16) 0.75 (0.66;0.86) <0.001
Pancreatic malignancy (Yes vs. No) 0.6 (0.26;0.95) 1.83 (1.29;2.59) 0.001
Metabolic disorder (Yes vs. No) -0.18 (-0.3;-0.06) 0.84 (0.74;0.94) 0.003
Pleural effusion (Yes vs. No) 0.18 (0.05;0.3) 1.19 (1.05;1.35) 0.006
Liver Dysfunction Syndrome (Yes vs. No) 0.61 (0.25;0.96) 1.83 (1.28;2.62) <0.001
Infections (Yes vs. No) 0.08 (-0.02;0.19) / ⇥
Pneumonia (Yes vs. No) 0.15 (0.03;0.26) 1.16 (1.04;1.29) 0.01
Urinary tract infection (Yes vs. No) -0.45 (-0.63;-0.28) 0.63 (0.53;0.76) <0.001
Skin or soft tissue infection (Yes vs. No) 0.4 (0.18;0.62) 1.49 (1.2;1.86) <0.001
Cholecystitis/cholangitis (Yes vs. No) -0.45 (-0.72;-0.18) 0.64 (0.49;0.83) <0.001
Primary bacteraemia of unknown origin (Yes vs. No) -0.39 (-0.66;-0.13) 0.67 (0.52;0.88) 0.004
Multiple trauma (Yes vs. No) -0.39 (-0.59;-0.19) 0.68 (0.56;0.83) <0.001
Traumatic brain injury (Yes vs. No) -0.18 (-0.4;0.04) / ⇥
Traumatic Subdural haematoma (Yes vs. No) 0.41 (0.13;0.69) 1.51 (1.14;2) 0.004
(to be continued)
°For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
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Comorbidities
Any tumour without metastasis (Yes vs. No tumor) 0.13 (0.03;0.22) 1.13 (1.03;1.25)
<0.001
Metastatic cancer (Yes vs. No tumor) 0.93 (0.79;1.07) 2.54 (2.21;2.93)
NYHA class II-III (Yes vs. None) 0.18 (0.1;0.27) 1.2 (1.1;1.31)
<0.001
NYHA class IV (Yes vs. None) 0.65 (0.47;0.83) 1.91 (1.6;2.29)
Malignant haematological disease (Yes vs. No) 0.55 (0.36;0.74) 1.73 (1.43;2.09) <0.001
Moderate or severe liver disease (Yes vs. No) 0.53 (0.35;0.7) 1.69 (1.42;2.02) <0.001
Severe COPD (Yes vs. No) 0.33 (0.23;0.43) 1.39 (1.25;1.54) <0.001
Severe malnutrition (Yes vs. No) 1.82 (0.75;2.89) / ⇥
Dementia (Yes vs. No) 0.2 (0.07;0.33) 1.23 (1.08;1.4) 0.002
Immunosuppression or AIDS (Yes vs. No) 0.55 (0.36;0.73) 1.73 (1.44;2.08) <0.001
Restrictive lung disease (Yes vs. No) 0.36 (0.19;0.52) 1.43 (1.22;1.69) / <0.001
Arrhythmia (Yes vs. No) 0.27 (0.18;0.35) / ⇥
Hypertension(Yes vs. No) -0.14 (-0.2;-0.07) 0.87 (0.82;0.93) <0.001
Cerebrovascular disease (Yes vs. No) 0.14 (0.06;0.22) 1.15 (1.06;1.25) 0.001
Autoimmune disease (Yes vs. No) 0.28 (0.11;0.44) 1.32 (1.12;1.55) <0.001
Organ failures
GCS (3,4 vs. 14-15) 2.78 (2.31;3.25) /
⇥
GCS (5 vs. 14-15) 2.17 (1.63;2.71) /
GCS (6 vs. 14-15) 2 (1.51;2.49) /
GCS (7,8,9,10 vs. 14-15) 0.64 (0.51;0.78) /
GCS (11,12,13 vs. 14-15) 0.32 (0.21;0.43) /
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 14-15) 1.16 (0.92;1.4) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 14-15) 0.65 (0.52;0.78) /
Neurologic failure (Cerebral coma vs. None or Not evaluable in the first 24 hours) 0.18 (0.03;0.33) 1.2 (1.03;1.39)
<0.001
Neurologic failure (Metabolic coma vs. None or Not evaluable in the first 24 hours) -0.25 (-0.44;-0.06) 0.78 (0.65;0.94)
Neurologic failure (Postanoxic coma vs. None or Not evaluable in the first 24 hours) -0.09 (-0.29;0.11) 0.92 (0.75;1.12)
Neurologic failure (Toxic coma vs. None or Not evaluable in the first 24 hours) -0.89 (-1.41;-0.38) 0.41 (0.24;0.69)
Cardiovascular failure (Neurogenic shock vs. None or Without shock) 0.9 (0.59;1.21) /
⇥Cardiovascular failure (Mixed shock vs. None or Without shock) 0.51 (0.3;0.71) /
Cardiovascular failure (Other shock vs. None or Without shock) 0.26 (0.17;0.34) /
Renal failure (AKIN) (Mild vs. None) 0.14 (0.05;0.22) /
⇥Renal failure (AKIN) (Moderate vs. None) 0.68 (0.52;0.83) /
Renal failure (AKIN) (Severe vs. None) 0.86 (0.67;1.05) /
Respiratory failure (Yes vs. No) 0.36 (0.28;0.45) / ⇥
Metabolic failure (Yes vs. No) 0.24 (0.16;0.31) 1.27 (1.18;1.37) <0.001
Surgical and non surgical procedures
Nephro/Urological surgery (Yes vs. No) -0.59 (-0.82;-0.36) 0.55 (0.44;0.7) <0.001
Orthopaedic surgery (Yes vs. No) -0.31 (-0.5;-0.11) 0.74 (0.61;0.89) 0.001
Peripheral vascular surgery (Yes vs. No) 0.37 (0.13;0.61) 1.45 (1.14;1.85) 0.003
Abdominal vascular surgery (Yes vs. No) 0.28 (0.07;0.49) 1.33 (1.07;1.64) 0.01
Interactions among independent variables
GCS (3,4,5,6)⇥ Platelets (103 /mm3) (<50) -0.79 (-1.19;-0.39) / <0.001
GCS (3,4,5,6)⇥ PaO2/FiO2 (100*mmHg/%) (<200) -0.65 (-0.85;-0.45) /
<0.001
GCS Not evaluable in the first 24 hours in neurological patient*⇥ PaO2/FiO2 (100*mmHg/%) (<200) -0.33 (-0.65;-0.01) /
GCS (3,4,5)⇥ PaO2/FiO2 (100*mmHg/%) (<300) -0.35 (-0.56;-0.13) /
GCS (7,8,9,10)⇥ PaO2/FiO2 (100*mmHg/%) (<100) -0.6 (-0.92;-0.27) /
GCS (3,4)⇥ Serum urea (mg/100 ml) (>=60) -0.23 (-0.44;-0.02) / 0.034
Serum urea (mg/100 ml) (>=180)⇥ Urine Output (L/24h) (<0.5) -0.35 (-0.6;-0.11) / 0.004
Sodium (mEq/L) (>=145)⇥ Urine Output (L/24h) (<0.5) -0.33 (-0.56;-0.09) / 0.007
Heart rate (bpm) (<70)⇥ Urine Output (L/24h) (<1) 0.38 (0.21;0.54) / <0.001
Surgical status (Non surgical)⇥ Renal failure (AKIN) (Moderate or Severe) -0.39 (-0.53;-0.24) / <0.001
GCS (3,4)⇥ Infections -0.56 (-0.81;-0.31) /
<0.001GCS Not evaluable in the first 24 hours in neurological patient*⇥ Infections -0.59 (-0.96;-0.21) /
GCS Not evaluable in the first 24 hours in NON-neurological patient*⇥ Infections -0.2 (-0.38;-0.03) /
GCS (3,4)⇥Ward of admission - Emergency room 0.66 (0.43;0.88) /
<0.001
GCS (5)⇥Ward of admission - Emergency room 1.55 (1;2.4) /
GCS (6)⇥Ward of admission - Emergency room 0.3 (-0.06;0.66) /
GCS (7,8,9,10)⇥Ward of admission - Emergency room 0.26 (0.06;0.46) /
GCS (11,12,13)⇥Ward of admission - Emergency room 0.21 (0.01;0.42) /
GCS (Not evaluable in the first 24 hours in neurological patient*)⇥Ward of admission - Emergency room 0.67 (0.39;0.94) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient*)⇥Ward of admission - Emergency room 0.19 (0;0.39) /
GCS (3,4,5,6)⇥ Age -0.01 (-0.02;-0.01) / <0.001
GCS (3,4,5,6)⇥ Spontaneous Intraparenchymal bleeding 0.64 (0.33;0.94) / <0.001
Severe malnutrition⇥ Age -0.02 (-0.04;-0.01) / 0.01
Arrhythmia⇥ Neurogenic shock or Mixed shock or Other shock -0.28 (-0.43;-0.13) / <0.001
GCS (3,4)⇥ Traumatic brain injury 0.72 (0.37;1.07) / <0.001
Ward of admission: Other ICU because of Step-up care⇥ Renal failure (AKIN) - Mild -0.25 (-0.78;0.27) /
0.039
Ward of admission: Other ICU because of Step-up care⇥ Renal failure (AKIN) - Moderate or Severe -0.66 (-1.17;-0.15) /
Age⇥ Stay before ICU (days) (>28) -0.02 (-0.03;-0.01) / <0.001
GCS (<11,Not evaluable in the first 24 hours)⇥ Stay before ICU (days) (>28) -0.44 (-0.76;-0.11) / 0.008
Respiratory failure⇥ Stay before ICU (days) (>28) -0.33 (-0.66;0) / 0.053
Dependent variable explained
Likelihood Ratio Test: 11254
Degree of freedom: 136
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.843
GiViTI Calibration Test: 1.54
p-value: 0.214
Polynomial Degree: 2
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haematoma, Traumatic intraparenchymal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
⇥ See interaction significance.
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National report for general ICUs - Year 2013
Prognostic models - Adult patients with LOS<24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality°.
Sample used for model development: Patients with LOS<24 hours from general Italian ICUs.
Sample size: 14548 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -5.92 (-6.49;-5.36) / /
Miscellanea
Age in decades 0.36 (0.30;0.42) 1.43 (1.35;1.52) <0.001
Body mass Index (BMI) (Underweight vs. Normal) 0.45 (0.18;0.72) 1.57 (1.2;2.05)
<0.001
Body mass Index (BMI) (Overweight or Obese vs. Normal) -0.38 (-0.54;-0.22) 0.69 (0.58;0.8)
Surgical status (Non surgical vs. Elective surgical) 0.01 (-0.4;0.42) 1.01 (0.67;1.53) ⇥
Surgical status (Emergency surgical vs. Elective surgical) 0.45 (0.22;0.69) 1.57 (1.24;1.99)
Stay before ICU (days) (logarithm) 0.25 (0.17;0.33) 1.28 (1.18;1.39) <0.001
Reason for admission (Intensive Treatment vs. Monitoring/Weaning) -0.44 (-0.9;0.03) 0.65 (0.41;1.03) 0.063
Ward of admission: Medical ward vs. Surgical ward 0.69 (0.39;0.99) 1.99 (1.48;2.68)
<0.001
Ward of admission: Emergency room vs. Surgical ward 0.22 (-0.07;0.51) 1.24 (0.93;1.66)
Ward of admission: High dependency care unit vs. Surgical ward 0.19 (-0.48;0.87) 1.21 (0.62;2.39) /
Ward of admission: Other ICU because of Specialist expertise vs. Surgical ward 0.14 (-0.85;1.13) 1.15 (0.43;3.1)
Ward of admission: Other ICU because of Step-up care vs. Surgical ward 0.25 (-0.69;1.2) 1.29 (0.5;3.32)
Ward of admission: Other ICU because of Logistical/organizational reasons vs. Surgical ward 0.72 (-0.04;1.48) 2.05 (0.96;4.4)
Ward of admission: Long-term chronic care hospital vs. Surgical ward 1.01 (-0.31;2.32) 2.73 (0.73;10.2)
Operating theatre (Yes vs. No) -0.99 (-1.35;-0.63) 0.37 (0.26;0.53) <0.001
Physiopatological components
Bilirubin (mg/100ml) (>=4 vs. <4) 0.89 (0.47;1.32) 2.44 (1.59;3.73) 0.001
Heart rate (bpm) (<40 vs. 40-119) 0.74 (0.27;1.2) 2.09 (1.31;3.33)
<0.001
Heart rate (bpm) (>=120 vs. 40-119) 0.29 (0.05;0.53) 1.34 (1.05;1.71)
WBC (109 /L) (>20 vs. <=20) 0.4 (0.14;0.66) 1.49 (1.15;1.94) 0.003
HCO3 (mEq/L) (<15 vs. >=15) 0.61 (0.29;0.94) 1.84 (1.33;2.55) <0.001
Systolic Blood Pressure (mmHg) (<70 vs. 100-199) 0.56 (0.11;1.02) /
⇥Systolic Blood Pressure (mmHg) (70-99 vs. 100-199) -0.04 (-0.3;0.22) /
Systolic Blood Pressure (mmHg) (>=200 vs. 100-199) -0.48 (-1.03;0.07) /
Urine Output (L/24h) (<0.49 vs. >=1) 1.14 (0.81;1.48) / ⇥
Urine Output (L/24h) (0.5-0.99 vs. >=1) 0.44 (0.18;0.7) /
PaO2/FiO2 (100*mmHg/%) (100-199 vs. >=200) 0.3 (0.09;0.51) 1.35 (1.1;1.67)
<0.001
PaO2/FiO2 (100*mmHg/%) (<100 vs. >=200) 0.97 (0.53;1.42) 2.65 (1.69;4.14)
Serum urea (mg/100 ml) (>=60 vs. <60) 0.38 (0.2;0.56) 1.46 (1.22;1.75) <0.001
Clinical conditions on admission
Spontaneous Intraparenchymal bleeding (Yes vs. No) 1.09 (0.56;1.63) / ⇥
Ascites (Yes vs. No) 2.28 (1.37;3.18) 9.75 (3.94;24.16) <0.001
Spontaneous Subarachnoid haemorrhage (Yes vs. No) 1.19 (0.63;1.75) 3.28 (1.88;5.73) <0.001
Ruptured or fissured aneurysm (Yes vs. No) 1.26 (0.68;1.85) 3.54 (1.97;6.37) <0.001
Seizures (Yes vs. No) -1.05 (-1.76;-0.33) 0.35 (0.17;0.72) 0.002
Acute intoxication (Yes vs. No) -1.07 (-1.89;-0.25) 0.34 (0.15;0.78) 0.006
Pulmonary embolism (Yes vs. No) 0.93 (0.22;1.65) 2.54 (1.24;5.19) 0.013
Infections (Yes vs. No) 0.26 (-0.02;0.54) 1.3 (0.98;1.71) 0.072
Comorbidities
Metastatic cancer (Yes vs. No) 0.75 (0.49;1.01) 2.12 (1.64;2.75) <0.001
Restrictive lung disease (Yes vs. No) 0.66 (0.23;1.08) 1.93 (1.26;2.95) 0.004
Malignant haematological disease (Yes vs. No) 0.94 (0.46;1.42) 2.55 (1.58;4.12) <0.001
NYHA class IV (Yes vs. No) 1 (0.56;1.43) 2.71 (1.76;4.16) <0.001
Organ failures
GCS (3,4 vs. 15) 2.98 (2.49;3.47) /
⇥
GCS (5,6,7,8 vs. 15) 1.3 (0.84;1.76) /
GCS (9,10,11,12,13,14 vs. 15) 0.61 (0.4;0.82) /
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 15) 1.04 (0.46;1.62) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 15) 0 (-0.47;0.46) /
Cardiovascular failure (Without shock vs. None) 0.78 (0.34;1.23) 2.19 (1.4;3.42)
<0.001
Cardiovascular failure (Cardiogenic shock vs. None) 0.8 (0.4;1.2) 2.23 (1.49;3.33)
Cardiovascular failure (Septic shock vs. None) 1.06 (0.47;1.66) 2.9 (1.59;5.27)
Cardiovascular failure (Haemorrhagic/hypovolemic shock vs. None) 1.15 (0.68;1.61) 3.15 (1.98;5.01)
Cardiovascular failure (Hypovolemic shock vs. None) 1.06 (0.43;1.69) 2.88 (1.53;5.41)
Cardiovascular failure (Neurogenic shock vs. None) 1.69 (0.67;2.71) 5.42 (1.95;15.04)
Cardiovascular failure (Other shock vs. None) 1.27 (0.41;2.12) 3.55 (1.51;8.33)
Cardiovascular failure (Mixed shock vs. None) 1.48 (0.36;2.59) 4.37 (1.43;13.33)
Respiratory failure (Only hypoxic failure vs. None) 0.83 (0.37;1.28) 2.28 (1.44;3.61)
0.004
Respiratory failure (Only hypercapnic failure vs. None) 0.58 (-0.06;1.22) 1.79 (0.95;3.39)
Respiratory failure (Hypoxic-hypercapnic failure vs. None) 0.95 (0.4;1.49) 2.58 (1.5;4.45)
Respiratory failure (Intubation for airway maint. vs. None) 0.59 (0.15;1.03) 1.8 (1.16;2.79)
Surgical and non surgical procedures
Gastrointestinal surgery (Yes vs. No) 0.55 (0.35;0.76) 1.74 (1.42;2.14) <0.001
Pancreatic surgery (Yes vs. No) 0.76 (0.27;1.26) 2.14 (1.31;3.52) 0.005
Interventional cardiology (Yes vs. No) -0.57 (-1.09;-0.05) 0.57 (0.34;0.95) 0.028
° For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haematoma, Traumatic intraparenchymal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
PROSAFE project
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National report for general ICUs - Year 2014
Prognostic models - Adult patients with LOS>=to 24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality°.
Sample used for model development: Patients with LOS>=24 hours from general Italian ICUs.
Sample size: 34832 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -5.68 (-5.86;-5.49) / /
Miscellanea
Max(Age - 41 , 0) in decades 0.41 (0.38;0.43) / ⇥
Min((BMI - 33)/10, 0)2 0.21 (0.16;0.26) 1.24 (1.18;1.3)
<0.001
Max((BMI - 33)/10, 0)2 0.06 (0.02;0.09) 1.06 (1.03;1.1)
Surgical status (Non surgical vs. Elective surgical) 0.76 (0.62;0.89) / ⇥
Surgical status (Emergency surgical vs. Elective surgical) 0.38 (0.25;0.5) /
Stay before ICU (days) (logarithm) 0.26 (0.22;0.31) 1.3 (1.25;1.36) <0.001
Admitted in hospital the same day of ICU admission (Yes vs. No) 0.08 (-0.02;0.18) 1.09 (0.98;1.2) 0.10
Ward of admission: Medical ward, High dependency care unit, Long-term chronic care hospital vs. Surgical ward, Other ICU 0.27 (0.18;0.36) / ⇥
Ward of admission: Emergency room vs. Surgical ward, Other ICU 0.09 (-0.02;0.2) /
Physiopatological components
Bilirubin (mg/100ml) (1.2-5.9 vs. <1.2) 0.2 (0.12;0.28) 1.22 (1.13;1.32)
<0.001
Bilirubin (mg/100ml) (>=6 vs. <1.2) 0.76 (0.52;1) 2.14 (1.68;2.73)
WBC (109 /L) (<1 vs. 1-20) 0.3 (0.06;0.53) 1.35 (1.07;1.71)
0.007
WBC (109 /L) (>20 vs. 1-20) 0.09 (0.01;0.18) 1.1 (1.01;1.2)
Sodium (mEq/L) (<125 vs. 125-145) 0.31 (0.07;0.56) 1.37 (1.07;1.74)
<0.001
Sodium (mEq/L) (>=145 vs. 125-145) 0.15 (0.06;0.24) 1.17 (1.07;1.27)
Platelets (103 /mm3) (20-99 vs. >=100) 0.32 (0.22;0.41) 1.37 (1.25;1.51)
<0.001
Platelets (103 /mm3) (<20 vs. >=100) 0.73 (0.45;1.01) 2.07 (1.56;2.74)
Urine Output (L/24h) (<0.2 vs. >=1) 0.77 (0.59;0.95) 2.16 (1.81;2.59)
<0.001Urine Output (L/24h) (0.2-0.49 vs. >=1) 0.48 (0.34;0.63) 1.62 (1.4;1.87)
Urine Output (L/24h) (0.5-0.99 vs. >=1) 0.3 (0.21;0.4) 1.36 (1.24;1.49)
Serum urea (mg/100 ml) (60-179 vs. <60) 0.2 (0.11;0.28) / ⇥
Serum urea (mg/100 ml) (>=180 vs. <60) 0.43 (0.28;0.59) /
PaO2/FiO2 (100*mmHg/%) (200-299 vs. >=300) 0.14 (0.05;0.23) /
⇥PaO2/FiO2 (100*mmHg/%) (100-199 vs. >=300) 0.46 (0.36;0.56) /
PaO2/FiO2 (100*mmHg/%) (<100 vs. >=300) 1.1 (0.9;1.3) /
Heart rate (bpm) (<70 vs. 70-119) -0.16 (-0.24;-0.08) / ⇥
Heart rate (bpm) (>=120 vs. 70-119) 0.28 (0.19;0.37) /
MAP (mmHg) (<70 vs. >=70) 0.31 (0.24;0.39) / ⇥
Potassium (mEq/L) (>=5 vs. <5) 0.22 (0.13;0.32) 1.25 (1.13;1.37) <0.001
Creatinine (mg/dl) (1.2-4.9 vs. <1.2) 0.15 (0.06;0.24) 1.16 (1.06;1.27)
<0.001
Creatinine (mg/dl) (>5 vs. <1.2) -0.48 (-0.68;-0.28) 0.62 (0.5;0.76)
Clinical conditions on admission
Acute intoxication (Yes vs. No) -0.76 (-1.09;-0.43) 0.47 (0.33;0.65) <0.001
Spontaneous Intraparenchymal bleeding (Yes vs. No) 0.78 (0.6;0.96) / ⇥
ARDS (Yes vs. No) 0.57 (0.38;0.77) / ⇥
Haematological disease (Yes vs. No) 0.74 (0.38;1.09) 2.09 (1.46;2.98) <0.001
Ascites (Yes vs. No) 0.71 (0.36;1.06) 2.03 (1.43;2.89) <0.001
Lung cancer (Yes vs. No) 0.8 (0.5;1.09) 2.22 (1.65;2.99) <0.001
Acute pancreatitis (Yes vs. No) 0.45 (0.18;0.73) 1.57 (1.19;2.07) 0.002
Seizures (Yes vs. No) -0.45 (-0.65;-0.25) 0.64 (0.52;0.78) <0.001
Bowel ischaemia (Yes vs. No) 0.63 (0.4;0.86) 1.88 (1.5;2.37) <0.001
Spontaneous Subarachnoid haemorrhage (Yes vs. No) 0.79 (0.58;1.01) 2.21 (1.78;2.75) <0.001
Cardiac arrest (Yes vs. No) 0.49 (0.29;0.69) / ⇥
Cerebral artery stroke (Yes vs. No) 0.3 (0.12;0.48) 1.35 (1.13;1.62) 0.001
Left heart failure with pulmonary edema (Yes vs. No) -0.37 (-0.5;-0.23) 0.69 (0.6;0.8) <0.001
Metabolic disorder (Yes vs. No) -0.17 (-0.3;-0.04) 0.84 (0.74;0.96) 0.008
Nephro-urologic disease (Yes vs. No) -0.29 (-0.45;-0.13) 0.75 (0.64;0.88) <0.001
Gastrointestinal bleeding: upper tract (Yes vs. No) 0.8 (0.49;1.1) / ⇥
Acute on chronic liver disease (Yes vs. No) 0.67 (0.22;1.12) 1.95 (1.24;3.07) 0.003
Vertebral basilar ischemic stroke (Yes vs. No) 0.8 (0.35;1.24) 2.22 (1.42;3.46) <0.001
Pneumothorax/Pneumomediastinum (Yes vs. No) 0.59 (0.25;0.93) 1.8 (1.28;2.54) <0.001
Brain tumour (Yes vs. No) 0.77 (0.48;1.06) 2.16 (1.62;2.88) <0.001
Post transplantation (Yes vs. No) -0.92 (-1.29;-0.55) 0.4 (0.28;0.58) <0.001
Systemic hypertensive crisis (Yes vs. No) -0.49 (-0.85;-0.13) 0.61 (0.43;0.88) 0.006
Ruptured or fissured aneurysm (Yes vs. No) 0.41 (0.13;0.69) 1.51 (1.14;1.99) 0.004
Pneumonia (Yes vs. No) 0.34 (0.21;0.47) / ⇥
Urinary tract infection (Yes vs. No) -0.27 (-0.45;-0.08) 0.77 (0.64;0.92) 0.005
Skin or soft tissue infection (Yes vs. No) 0.6 (0.37;0.82) 1.82 (1.45;2.28) <0.001
Cholecystitis/cholangitis (Yes vs. No) -0.44 (-0.71;-0.16) 0.65 (0.49;0.85) 0.001
Peritonites (Yes vs. No) 0.32 (0.15;0.49) 1.38 (1.16;1.64) <0.001
Infection severity on admission (Infection with or without SIRS vs. None) -0.12 (-0.26;0.01) /
⇥Infection severity on admission (Severe sepsis vs. None) 0.84 (0.34;1.35) /
Infection severity on admission (Septic shock vs. None) 0.05 (-0.1;0.2) /
Multiple trauma (Yes vs. No) -0.4 (-0.6;-0.2) 0.67 (0.55;0.82) <0.001
Traumatic Subdural haematoma (Yes vs. No) 0.58 (0.29;0.88) 1.79 (1.33;2.41) <0.001
Traumatic intraparenchymal bleeding (Yes vs. No) 0.52 (0.11;0.93) 1.69 (1.12;2.54) 0.013
Spine trauma (Trauma with deficit vs. No trauma or Trauma without deficit) 0.88 (0.45;1.32) 2.42 (1.56;3.76) <0.001
Post-traumatic diffuse injury (Yes vs. No) 0.64 (0.18;1.1) 1.9 (1.2;3.01) 0.007
Head trauma (Head trauma without skull fracture vs. No head trauma) -0.4 (-0.79;-0.02) / ⇥
Head trauma (Head trauma with skull fracture vs. No head trauma) -0.03 (-0.4;0.35) /
(to be continued)
°For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
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Comorbidities
Metastatic cancer (Yes vs. No) 0.96 (0.82;1.1) 2.61 (2.27;3) <0.001
NYHA class II-III (Yes vs. None) 0.21 (0.12;0.3) 1.23 (1.13;1.35)
<0.001
NYHA class IV (Yes vs. None) 0.5 (0.31;0.68) 1.65 (1.37;1.98)
Malignant haematological disease (Yes vs. No) 0.69 (0.49;0.89) 1.99 (1.64;2.43) <0.001
Moderate or severe liver disease (Yes vs. No) 0.56 (0.37;0.75) 1.75 (1.45;2.12) <0.001
Severe COPD (Yes vs. No) 0.4 (0.3;0.51) 1.5 (1.35;1.67) <0.001
Severe malnutrition (Yes vs. No) 0.5 (0.24;0.76) 1.64 (1.27;2.13) <0.001
Dementia (Yes vs. No) 0.43 (0.29;0.58) / ⇥
Immunosuppression or AIDS (Yes vs. No) 0.3 (0.1;0.5) 1.35 (1.11;1.64) 0.003
Restrictive lung disease (Yes vs. No) 0.46 (0.29;0.63) 1.58 (1.34;1.87) / <0.001
Hypertension (Yes vs. No) -0.13 (-0.2;-0.07) 0.88 (0.82;0.94) <0.001
Cerebrovascular disease (Yes vs. No) 0.13 (0.04;0.21) 1.14 (1.04;1.24) 0.003
Peripheral vascular disease (Yes vs. No) 0.23 (0.13;0.33) 1.26 (1.14;1.38) <0.001
Diabetes Type II with insulin treatment (Yes vs. No) 0.19 (0.08;0.3) 1.21 (1.09;1.35) <0.001
Organ failures
GCS (3,4 vs. 15) 2.43 (2.17;2.7) /
⇥
GCS (5 vs. 15) 1.64 (1.37;1.91) /
GCS (6 vs. 15) 1.41 (1.17;1.65) /
GCS (7,8,9 vs. 15) 0.94 (0.79;1.1) /
GCS (10,11,12 vs. 15) 0.48 (0.35;0.62) /
GCS (13,14 vs. 15) 0.29 (0.18;0.4) /
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 15) 1.24 (1.04;1.44) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 15) 0.57 (0.44;0.7) /
Neurologic failure (Cerebral coma vs. None or Not evaluable in the first 24 hours) 0.25 (0.09;0.42) /
⇥Neurologic failure (Metabolic coma vs. None or Not evaluable in the first 24 hours) -0.56 (-0.77;-0.36) /
Neurologic failure (Postanoxic coma vs. None or Not evaluable in the first 24 hours) 0.38 (0.04;0.71) /
Neurologic failure (Toxic coma vs. None or Not evaluable in the first 24 hours) -0.95 (-1.46;-0.43) /
Cardiogenic shock (Yes vs. No) 0.35 (0.23;0.47) 1.42 (1.26;1.6) <0.001
Neurogenic shock (Yes vs. No) 0.94 (0.62;1.27) 2.57 (1.85;3.56) <0.001
Non shock (Yes vs. No) 0.17 (0.05;0.29) 1.19 (1.05;1.34) 0.005
Haemorrhagic-Hypovolemic shock (Yes vs. No) 0.14 (-0.01;0.29) 1.15 (0.99;1.34) 0.069
Hypovolemic (non-haemorrhagic) shock (Yes vs. No) 0.05 (-0.14;0.23) / ⇥
Renal failure (AKIN) (Mild vs. None) 0.09 (-0.01;0.19) /
⇥Renal failure (AKIN) (Moderate vs. None) 0.48 (0.33;0.63) /
Renal failure (AKIN) (Severe vs. None) 0.78 (0.59;0.97) /
Respiratory failure (Only hypoxic failure vs. None) 0.32 (0.22;0.41) /
⇥Respiratory failure (Only hypercapnic failure vs. None) 0.26 (0.1;0.41) /
Respiratory failure (Intubation for airway maint. vs. None) 0.42 (0.32;0.51) /
Metabolic failure (pH <= 7.3, PaCO2 < 45 mmHg vs. None) 0.44 (0.33;0.55) / ⇥
Metabolic failure (gsub("˚","",formato("metabolicFail","baseMetaFail")) vs. None) 0.23 (0.14;0.32) /
Surgical and non surgical procedures
Peripheral vascular surgery (Yes vs. No) 0.35 (0.09;0.61) 1.42 (1.1;1.84) 0.009
Gastrointestinal surgery (Yes vs. No) 0.31 (0.19;0.43) 1.36 (1.2;1.53) <0.001
Pancreatic surgery (Yes vs. No) 0.54 (0.19;0.88) 1.71 (1.21;2.41) 0.003
Interactions among independent variables
GCS (10,11,12,Not evaluable in the first 24 hours in NON-neurological patient*)⇥ Heart rate (bpm) (>120) -0.35 (-0.52;-0.17) /
<0.001
GCS (Not evaluable in the first 24 hours in neurological patient*)⇥ Heart rate (bpm) (<70) 0.49 (0.19;0.78) /
GCS (3,4)⇥ Serum urea (mg/100 ml) (60-180) -0.27 (-0.49;-0.04) /
<0.001
GCS (3,4)⇥ Serum urea (mg/100 ml) (>180) -1.05 (-1.56;-0.55) /
GCS (3,4)⇥ PaO2/FiO2 (100*mmHg/%) (200-300) -0.33 (-0.58;-0.08) /
<0.001
GCS (10,11,12,Not evaluable in the first 24 hours in NON-neurological patient*)⇥ PaO2/FiO2 (100*mmHg/%) (200-300) 0.21 (0.05;0.36) /
GCS (3,4)⇥ PaO2/FiO2 (100*mmHg/%) (100-200) -0.76 (-1.02;-0.5) /
GCS (5,6,7,8,9,Not evaluable in the first 24 hours in neurological patient*)⇥ PaO2/FiO2 (100*mmHg/%) (100-200) -0.28 (-0.45;-0.11) /
GCS (3,4,5,6,Not evaluable in the first 24 hours in neurological patient*)⇥ PaO2/FiO2 (100*mmHg/%) (<100) -1.15 (-1.51;-0.79) /
GCS (7,8,9,13,14)⇥ PaO2/FiO2 (100*mmHg/%) (<100) -0.63 (-0.93;-0.32) /
GCS (10,11,12,Not evaluable in the first 24 hours in NON-neurological patient*)⇥ PaO2/FiO2 (100*mmHg/%) (<100) -0.32 (-0.59;-0.05) /
Pneumonia⇥ Renal failure (AKIN) (Severe) -0.42 (-0.7;-0.15) / 0.002
GCS (3,4,5,6)⇥ Dementia -0.53 (-0.9;-0.16) / 0.005
ARDS⇥ Infection severity on admission (Septic shock) -0.57 (-0.94;-0.2) / 0.003
Infection severity on admission (Infection with or without SIRS)⇥ Renal failure (AKIN) (Severe) -0.36 (-0.72;0.01) /
0.002
Infection severity on admission (Severe sepsis,Septic shock)⇥ Renal failure (AKIN) (Moderate) -0.27 (-0.46;-0.07) /
Respiratory failure (Only hypercapnic failure)⇥ Neurologic failure (Cerebral coma) -0.82 (-1.51;-0.14) / 0.016
GCS (3,4,5,6)⇥ Head trauma with skull fracture 0.75 (0.23;1.26) / 0.004
Max(Age - 41 , 0) in decades⇥ Head trauma without skull fracture 0.14 (0.03;0.24) / 0.008
Max(Age - 41 , 0) in decades⇥ Neurologic failure (Postanoxic coma) -0.15 (-0.25;-0.06) / 0.002
GCS (3,4,Not evaluable in the first 24 hours in neurological patient*)⇥ Infection severity on admission (Infection with or without SIRS) -0.47 (-0.8;-0.15) / 0.004
MAP (mmHg) (<70)⇥ Gastrointestinal bleeding: upper tract -0.79 (-1.25;-0.32) / <0.001
GCS (3,4)⇥ Spontaneous Intraparenchymal bleeding 0.76 (0.42;1.11) / <0.001
Surgical status (Non surgical)⇥ Infection severity on admission (Severe sepsis) -0.93 (-1.44;-0.42) /
0.002
Surgical status (Emergency surgical)⇥ Infection severity on admission (Severe sepsis) -0.84 (-1.38;-0.3) /
Hypovolemic (non-haemorrhagic) shock⇥ Metabolic failure (pH <= 7.3, PaCO2 < 45 mmHg) -0.48 (-0.91;-0.04) / 0.032
MAP (mmHg) (<70)⇥ Cardiac arrest -0.45 (-0.69;-0.2) / <0.001
GCS (3,4,Not evaluable in the first 24 hours in neurological patient*,Not evaluable in the first 24 hours in NON-neurological patient*)⇥
Ward of admission (Emergency room)
0.28 (0.15;0.42) / <0.001
Dependent variable explained
Likelihood Ratio Test: 11570
Degree of freedom: 139
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.851
GiViTI Calibration Test: 1.71
p-value: 0.191
Polynomial Degree: 2
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haematoma, Traumatic intraparenchymal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
⇥ See interaction significance.
PROSAFE project
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National report for general ICUs - Year 2014
Prognostic models - Adult patients with LOS<24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality°.
Sample used for model development: Patients with LOS<24 hours from general Italian ICUs.
Sample size: 13807 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -6.88 (-7.51;-6.26) / /
Miscellanea
Max(Min(Age, 86), 36) (in decades) 0.39 (0.32;0.46) 1.48 (1.38;1.59)
<0.001
Max(Age - 86, 0) (in decades) 0.95 (0.43;1.47) 2.58 (1.53;4.34)
Min(BMI - 24, 0) -0.09 (-0.13;-0.05) 0.91 (0.88;0.95) <0.001
Surgical status (Non surgical vs. Elective surgical) 0.65 (0.26;1.05) 1.92 (1.29;2.85)
<0.001
Surgical status (Emergency surgical vs. Elective surgical) 0.59 (0.36;0.82) 1.8 (1.44;2.26)
Stay before ICU (days) (logarithm) 0.32 (0.24;0.39) 1.37 (1.27;1.48) <0.001
Operating theatre (Yes vs. No) -0.79 (-1.16;-0.42) 0.45 (0.31;0.66) <0.001
Ward of admission: High dependency care unit vs. Other ward 0.77 (0.13;1.4) 2.15 (1.14;4.07) 0.021
Physiopatological components
Heart rate (bpm) (<40 vs. 40-119) 1.01 (0.51;1.52) 2.75 (1.66;4.56)
<0.001
Heart rate (bpm) (>=120 vs. 40-119) 0.33 (0.08;0.59) 1.4 (1.08;1.8)
WBC (109 /L) (>20 vs. <=20) 0.61 (0.34;0.89) / ⇥
HCO3 (mEq/L) (<15 vs. >=20) 0.62 (0.27;0.97) 1.85 (1.3;2.63)
0.002
HCO3 (mEq/L) (15-19 vs. >=20) 0.23 (0.01;0.44) 1.26 (1.01;1.56)
Platelets (103 /mm3) (<100 vs. >=100) 0.65 (0.37;0.93) 1.92 (1.44;2.55) <0.001
Systolic Blood Pressure (mmHg) (<70 vs. >=100) 0.66 (0.24;1.08) / ⇥
Systolic Blood Pressure (mmHg) (70-99 vs. >=100) 0.14 (-0.11;0.38) /
Urine Output (L/24h) (<0.2 vs. >=1) 1.45 (0.99;1.9) /
⇥Urine Output (L/24h) (0.2-0.49 vs. >=1) 0.95 (0.58;1.32) /
Urine Output (L/24h) (0.5-0.99 vs. >=1) 0.6 (0.38;0.82) /
PaO2/FiO2 (100*mmHg/%) (100-199 vs. >=200) 0.38 (0.16;0.59) 1.46 (1.17;1.81)
<0.001
PaO2/FiO2 (100*mmHg/%) (<100 vs. >=200) 1.38 (0.92;1.84) 3.99 (2.52;6.33)
Clinical conditions on admission
Spontaneous Intraparenchymal bleeding (Yes vs. No) 0.90 (0.43;1.37) 2.46 (1.54;3.94) <0.001
Nephro-urologic disease (Yes vs. No) -0.52 (-0.93;-0.11) 0.59 (0.39;0.9) 0.011
Ruptured or fissured aneurysm (Yes vs. No) 1.06 (0.46;1.66) 2.88 (1.58;5.24) <0.001
Pleural effusion (Yes vs. No) 0.87 (0.33;1.41) 2.39 (1.39;4.1) 0.002
Acute intoxication (Yes vs. No) -1.45 (-2.33;-0.58) 0.23 (0.10;0.56) <0.001
Bowel ischaemia (Yes vs. No) 0.82 (0.20;1.45) 2.28 (1.22;4.25) 0.011
Seizures (Yes vs. No) -1.29 (-2.00;-0.58) 0.27 (0.14;0.56) <0.001
Acute severe arrhythmia: bradycardias (Yes vs. No) -1.54 (-2.43;-0.64) 0.22 (0.09;0.53) <0.001
Peritonites (Yes vs. No) 0.69 (0.18;1.2) 1.99 (1.2;3.32) 0.009
Infection severity on admission (Severe sepsis vs. Infection with or without SIRS or None) -0.03 (-0.56;0.5) / ⇥
Infection severity on admission (Septic shock vs. Infection with or without SIRS or None) 0.57 (0.05;1.09) /
Comorbidities
Metastatic cancer (Yes vs. No) 1.02 (0.75;1.28) 2.76 (2.12;3.61) <0.001
Dementia (Yes vs. No) 0.63 (0.29;0.98) 1.88 (1.33;2.66) <0.001
Hypertension (Yes vs. No) -0.23 (-0.4;-0.06) 0.80 (0.67;0.94) 0.009
Arrhythmia (Yes vs. No) 0.34 (0.14;0.54) 1.40 (1.15;1.71) <0.001
Malignant haematological disease (Yes vs. No) 0.91 (0.39;1.43) 2.49 (1.48;4.19) 0.001
Moderate or severe liver disease (Yes vs. No) 0.9 (0.46;1.35) 2.47 (1.59;3.84) <0.001
Organ failures
GCS (3,4 vs. 15) 3.67 (3.2;4.14) /
⇥
GCS (5-10 vs. 15) 1.28 (0.94;1.62) /
GCS (11-14 vs. 15) 0.42 (0.19;0.66) /
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 15) 1.91 (1.44;2.38) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 15) 0.7 (0.4;0.99) /
Cardiovascular failure (Yes vs. No) 0.50 (0.24;0.76) 1.65 (1.27;2.15) <0.001
Metabolic failure (Yes vs. No) 0.44 (0.2;0.68) 1.55 (1.22;1.97) <0.001
Neurologic failure (Postanoxic coma or Toxic coma vs. None) -1.29 (-1.84;-0.75) 0.27 (0.16;0.47) <0.001
Renal failure (AKIN) (Moderate or Severe vs. None) 0.46 (0.16;0.76) 1.59 (1.18;2.14) 0.002
Respiratory failure (Yes vs. No) 0.37 (0.16;0.58) 1.44 (1.17;1.78) <0.001
Surgical and non surgical procedures
Gastrointestinal surgery (Yes vs. No) 0.57 (0.35;0.8) 1.78 (1.42;2.23) <0.001
Pancreatic surgery (Yes vs. No) 0.85 (0.29;1.42) 2.35 (1.34;4.12) 0.006
Interactions among independent variables
WBC (109 /L) (>20)⇥ Infection severity on admission (Severe sepsis) -1.21 (-2.36;-0.06) / 0.036
GCS (3-10, Not evaluable in the first 24 hours in neurological patient* or Not evaluable in the first 24 hours in NON-neurological
patient*)⇥ Systolic Blood Pressure (mmHg) (70-99)
0.77 (0.36;1.18) / <0.001
GCS (3-10, Not evaluable in the first 24 hours in neurological patient* or Not evaluable in the first 24 hours in NON-neurological
patient*)⇥ Systolic Blood Pressure (mmHg) (<70)
1.27 (0.71;1.84) / <0.001
Systolic Blood Pressure (mmHg) (<70)⇥ Urine Output (L/24h) (<0.2) 1.19 (0.34;2.04) / 0.003
Dependent variable explained
Likelihood ratio test: 9289.2
Degree of freedom: 54
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.961
GiViTI Calibration Test: 0.286
p-value: 0.593
Polynomial Degree: 2
° For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haematoma, Traumatic intraparenchymal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
PROSAFE project
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National report for general ICUs - Year 2015
Prognostic models - Adult patients with LOS>=to 24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality°.
Sample used for model development: Patients with LOS>=24 hours from general Italian ICUs.
Sample size: 31883 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -6.62 (-6.95;-6.29) / /
Miscellanea
Max(Min(Age,72),25) in decades 0.36 (0.32;0.4) / ⇥
Max((Age-72),0) in decades 0.51 (0.44;0.58) /
Min((BMI - 28)/10, 0)2 0.59 (0.48;0.7) / ⇥
Max((BMI - 28)/10, 0)2 0.34 (0.19;0.49) /
Surgical status (Non surgical vs. Elective surgical) 0.83 (0.67;0.98) 2.29 (1.96;2.67)
<0.001
Surgical status (Emergency surgical vs. Elective surgical) 0.31 (0.17;0.45) 1.36 (1.19;1.56)
Stay before ICU (days) (logarithm) 0.32 (0.27;0.36) 1.37 (1.31;1.44) <0.001
Admitted in hospital the same day of ICU admission (Yes vs. No) 0.08 (-0.03;0.19) / ⇥
Admission source: Other ICU - Logistical/organizational reasons vs. Surgical ward -0.52 (-0.73;-0.32) /
⇥
Admission source: Emergency room vs. Surgical ward 0.03 (-0.09;0.15) /
Admission source: Other hospital (Medical ward, High dependency care unit, Other ICU - Specialist expertise, Step-up care) vs.
Surgical ward
0.06 (-0.12;0.24) /
Admission source: Same hospital (Other ICU - Specialist expertise,Step-up care) vs. Surgical ward 0.66 (0.42;0.9) /
Admission source: Same hospital (Medical ward, High dependency care unit) vs. Surgical ward 0.29 (0.17;0.41) /
Admission source: Long-term chronic care hospital,Directly from the community vs. Surgical ward 0.33 (-0.08;0.73) /
Reason for admission: Weaning vs. Ventilatory and cardiovascular support, Only ventilatory support -0.34 (-0.5;-0.18) 0.71 (0.6;0.83)
<0.001Reason for admission: Monitoring vs. Ventilatory and cardiovascular support, Only ventilatory support -0.42 (-0.54;-0.3) 0.66 (0.58;0.74)
Reason for admission: Only cardiovascular support vs. Ventilatory and cardiovascular support, Only ventilatory support -0.35 (-0.51;-0.2) 0.7 (0.6;0.82)
Sex: Female vs. Male -0.05 (-0.12;0.01) / ⇥
Physiopatological components
Bilirubin (mg/100ml) (1.2-4 vs. <1.2) 0.04 (-0.05;0.13) / ⇥
Bilirubin (mg/100ml) (>=4 vs. <1.2) 0.78 (0.51;1.05) /
WBC (109 /L) (<1 vs. 1-20) 0.06 (-0.19;0.31) / ⇥
WBC (109 /L) (>20 vs. 1-20) 0.35 (0.21;0.49) /
Sodium (mEq/L) (>=145 vs. <145) 0.31 (0.22;0.41) 1.37 (1.25;1.5) <0.001
Platelets (103 /mm3) (50-99 vs. >=100) 0.4 (0.3;0.51) /
⇥Platelets (103 /mm3) (20-49 vs. >=100) 0.64 (0.45;0.82) /
Platelets (103 /mm3) (<20 vs. >=100) 1.45 (1.11;1.78) /
Urine Output (L/24h) (<0.2 vs. >=1) 0.72 (0.54;0.91) /
⇥Urine Output (L/24h) (0.2-0.49 vs. >=1) 0.47 (0.32;0.63) /
Urine Output (L/24h) (0.5-0.99 vs. >=1) 0.27 (0.17;0.36) /
Serum urea (mg/100 ml) (>=60 vs. <60) 0.3 (0.21;0.38) / ⇥
PaO2/FiO2 (100*mmHg/%) (200-299 vs. >=300) 0.2 (0.11;0.28) /
⇥PaO2/FiO2 (100*mmHg/%) (100-199 vs. >=300) 0.38 (0.29;0.48) /
PaO2/FiO2 (100*mmHg/%) (<100 vs. >=300) 1.31 (1.11;1.52) /
Heart rate (bpm) (<70 vs. 70-119) -0.04 (-0.13;0.05) / ⇥
Heart rate (bpm) (>=120 vs. 70-119) 0.14 (0.05;0.23) /
Systolic Blood Pressure (mmHg) (<70 vs. >=100) 0.66 (0.54;0.78) / ⇥
Systolic Blood Pressure (mmHg) (70-99 vs. >=100) 0.3 (0.21;0.38) /
Clinical conditions on admission
Acute intoxication (Yes vs. No) -0.89 (-1.22;-0.56) 0.41 (0.3;0.57) <0.001
Spontaneous Intraparenchymal bleeding (Yes vs. No) -0.12 (-0.43;0.19) / ⇥
ALI/ARDS (Yes vs. No) 0.39 (0.22;0.55) / ⇥
Lung cancer (Yes vs. No) 0.76 (0.39;1.12) / ⇥
Acute pancreatitis (Yes vs. No) 0.41 (0.13;0.69) 1.51 (1.14;2) 0.005
Seizures (Yes vs. No) -0.17 (-0.45;0.11) / ⇥
Bowel ischaemia (Yes vs. No) 0.43 (0.19;0.67) 1.54 (1.21;1.96) 0.001
Spontaneous Subarachnoid haemorrhage (Yes vs. No) 0.64 (0.34;0.94) / ⇥
Cardiac arrest (Yes vs. No) 0.56 (0.35;0.78) / ⇥
Cerebral artery stroke (Yes vs. No) 0.49 (0.31;0.68) 1.63 (1.36;1.97) <0.001
Left heart failure with pulmonary edema (Yes vs. No) -0.65 (-0.81;-0.49) / ⇥
Metabolic disorder (Yes vs. No) -0.22 (-0.35;-0.09) 0.81 (0.71;0.92) 0.001
Brain tumour (Yes vs. No) 0.45 (0.1;0.8) 1.57 (1.11;2.23) 0.013
Systemic hypertensive crisis (Yes vs. No) -0.67 (-1.08;-0.26) 0.51 (0.34;0.77) 0.001
Intracranial hypertension (Yes vs. No) 0.9 (0.41;1.39) 2.46 (1.51;4.01) <0.001
Other disease (Yes vs. No) -0.28 (-0.46;-0.1) 0.76 (0.63;0.91) 0.002
Urinary tract infection (Yes vs. No) -0.21 (-0.49;0.07) / ⇥
Cholecystitis/cholangitis (Yes vs. No) -0.56 (-0.83;-0.28) 0.57 (0.44;0.75) <0.001
Endocarditis (Yes vs. No) 0.85 (0.37;1.33) 2.34 (1.45;3.79) 0.001
Peritonites (Post-surgical or secondary vs. None or primary 0.33 (0.17;0.5) / ⇥
Peritonites (Tertiary vs. None or primary 0.88 (0.2;1.56) /
Infection severity on admission (Infection with or without SIRS vs. None) 0.02 (-0.1;0.13) /
⇥Infection severity on admission (Severe sepsis vs. None) 0.08 (-0.03;0.2) /
Infection severity on admission (Septic shock vs. None) 0.49 (0.23;0.74) /
Other injuries of the chest (Yes vs. No) -0.44 (-0.73;-0.15) 0.64 (0.48;0.86) 0.002
Traumatic Subdural haematoma (Yes vs. No) 0.42 (0.11;0.73) 1.52 (1.12;2.07) 0.008
Skull fracture (Yes vs. No) 0.57 (0.24;0.9) 1.77 (1.27;2.46) 0.001
Maxillofacial fracture (Yes vs. No) -0.53 (-0.87;-0.18) 0.59 (0.42;0.83) 0.002
Head trauma (Yes vs. No) -0.76 (-1.15;-0.38) / ⇥
(to be continued)
°For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
PROSAFE project
125 Models
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Comorbidities
Severe COPD (Yes vs. No) 0.42 (0.31;0.54) / ⇥
Dementia (Yes vs. No) 0.53 (0.38;0.68) / ⇥
Malignant haematological disease (Yes vs. No) 0.79 (0.54;1.04) / ⇥
Restrictive lung disease (Yes vs. No) 0.46 (0.29;0.63) 1.58 (1.33;1.88) <0.001
Hypertension (Yes vs. No) 0 (-0.08;0.09) / ⇥
Immunosuppression or AIDS (Yes vs. No) 0.34 (0.14;0.54) 1.41 (1.15;1.72) 0.001
Any tumour without metastasis (Yes vs. No tumor) 0.17 (0.07;0.28) / ⇥
Metastatic cancer (Yes vs. No tumor) 3.72 (2.57;4.87) /
NYHA class II-III (Yes vs. None) 0.06 (-0.05;0.18) / ⇥
NYHA class IV (Yes vs. None) 0.48 (0.28;0.69) /
Mild liver disease (Yes vs. No liver disease) 0.3 (0.09;0.51) / ⇥
Moderate or severe liver disease (Yes vs. No liver disease) 0.83 (0.6;1.07) /
Diabetes with insuline treatment (Yes vs. No) 0.15 (0.04;0.27) / ⇥
Organ failures
GCS (3,4 vs. 15) 2.36 (2.14;2.58) /
⇥
GCS (5,6 vs. 15) 1.58 (1.36;1.8) /
GCS (7,8,9 vs. 15) 0.93 (0.78;1.08) /
GCS (10 vs. 15) 0.41 (0.2;0.62) /
GCS (11,12,13,14 vs. 15) 0.27 (0.17;0.36) /
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 15) 1.24 (1.05;1.42) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 15) 0.68 (0.58;0.78) /
Neurologic failure (Cerebral coma vs. None or Not evaluable in the first 24 hours) 0.11 (-0.11;0.33) /
⇥Neurologic failure (Postanoxic coma vs. None or Not evaluable in the first 24 hours) 2.27 (1.44;3.11) /
Neurologic failure (Metabolic coma, Toxic coma vs. None or Not evaluable in the first 24 hours) -0.54 (-0.73;-0.34) /
Cardiovascular failure (Yes vs. No) 0.19 (0.05;0.33) / ⇥
Cardiovascular failure (Hypovolemic (non-haemorrhagic) shock, Cardiogenic shock vs. (other)) -0.06 (-0.24;0.12) / ⇥
Cardiogenic shock (Yes vs. No) 0.67 (0.42;0.91) / ⇥
Neurogenic shock (Yes vs. No) 1.03 (0.69;1.36) / ⇥
Metabolic failure (Yes vs. No) 0.23 (0.15;0.31) 1.26 (1.16;1.36) <0.001
Renal failure (AKIN) (Mild vs. None) 0.14 (0.04;0.23) /
⇥Renal failure (AKIN) (Moderate vs. None) 0.71 (0.51;0.91) /
Renal failure (AKIN) (Severe vs. None) 0.75 (0.5;1) /
Hepatic failure (Yes vs. No) 0.62 (0.29;0.95) 1.85 (1.33;2.58) <0.001
Surgical and non surgical procedures
Gastrointestinal surgery (Yes vs. No) 0.31 (0.19;0.44) 1.37 (1.21;1.55) <0.001
Abdominal vascular surgery (Yes vs. No) -4.4 (-7.8;-1) / ⇥
Interventional cardiology (Yes vs. No) -2.62 (-4.03;-1.22) / ⇥
Interactions among independent variables
GCS (3,4)⇥ Urine Output (L/24h) (0.2-0.49) -0.66 (-1.08;-0.23) /
<0.001GCS (7,8,9)⇥ Urine Output (L/24h) (<0.2) 0.61 (0.18;1.03) /
GCS (10)⇥ Urine Output (L/24h) (0.5-0.99) 0.78 (0.32;1.24) /
GCS (3,4,5,6)⇥ PaO2/FiO2 (100*mmHg/%) (100-199) -0.44 (-0.63;-0.25) /
<0.001
GCS (3,4,5,6)⇥ PaO2/FiO2 (100*mmHg/%) (<100) -0.67 (-0.99;-0.35) /
Serum urea (mg/100 ml) (>=60)⇥ PaO2/FiO2 (100*mmHg/%) (<100) -0.39 (-0.6;-0.17) / <0.001




GCS (3,4)⇥ Admission source (Same hospital - Medical ward, High dependency care unit) -0.57 (-0.84;-0.3) /
GCS (3,4,Not evaluable in the first 24 hours in neurological patient*)⇥ Spontaneous Intraparenchymal bleeding 0.8 (0.48;1.11) / <0.001
GCS (3,4,5,6,7,8,9)⇥ Infection severity on admission (Infection with or without SIRS, Severe sepsis) -0.35 (-0.53;-0.18) / <0.001
Systolic Blood Pressure (mmHg) (<100)⇥ Infection severity on admission (Septic shock) -0.42 (-0.68;-0.17) / 0.001
Sex (Male)⇥ Head trauma 0.53 (0.21;0.85) / 0.001
Sex (Male)⇥ Spontaneous Subarachnoid haemorrhage 0.58 (0.16;1.01) / 0.007
GCS (3,4)⇥ Head trauma 0.68 (0.32;1.03) / <0.001
Max(Age - 72 , 0) in decades⇥ Head trauma 0.74 (0.46;1.02) / <0.001
Max(Min(Age-72), 25) in decades⇥ Max((BMI - 28)/10, 0)2 -0.05 (-0.07;-0.02) / <0.001
Max(Min(Age-72), 25) in decades⇥ Metastatic cancer -0.41 (-0.58;-0.24) / <0.001
Max(Min(Age-72), 25) in decades⇥ Neurologic failure (Postanoxic coma -0.35 (-0.48;-0.23) / <0.001
Max(Min(Age-72), 25) in decades⇥ Interventional cardiology 0.33 (0.12;0.54) / 0.001
Max(Min(Age-72), 25) in decades⇥ Abdominal vascular surgery 0.69 (0.2;1.17) / 0.002
Admitted in hospital the same day of ICU admission⇥ Spontaneous Intraparenchymal bleeding 0.82 (0.49;1.14) / <0.001
Admitted in hospital the same day of ICU admission⇥ Seizures -0.68 (-1.1;-0.25) / 0.002
Admitted in hospital the same day of ICU admission⇥ Neurologic failure (Cerebral coma 0.35 (0.13;0.57) / 0.002
Admitted in hospital the same day of ICU admission⇥ Cardiogenic shock 0.26 (0.04;0.47) / 0.021
GCS (3,4)⇥ Dementia -0.62 (-1.05;-0.18) / 0.007
Dementia⇥ Peritonites (Post-surgical or secondary) -0.77 (-1.34;-0.21) / 0.007
Dementia⇥ ALI/ARDS -1.11 (-1.92;-0.3) / 0.006
Cardiovascular failure⇥ Admission source (Other ICU - Logistical/organizational reasons) 0.63 (0.24;1.01) / 0.001
Cardiovascular failure⇥ PaO2/FiO2 (100*mmHg/%) (<100) -0.48 (-0.69;-0.26) / <0.001
Cardiovascular failure⇥ Cardiac arrest -0.5 (-0.76;-0.24) / <0.001
Cardiovascular failure⇥ Hypertension -0.25 (-0.38;-0.12) / <0.001
Cardiovascular failure⇥ Neurologic failure (Cerebral coma -0.32 (-0.56;-0.08) / 0.010
Cardiovascular failure⇥ Bilirubin (mg/100ml) (>=4) -0.54 (-0.89;-0.18) / 0.003
Cardiovascular failure⇥ Urinary tract infection -0.64 (-1;-0.29) / <0.001
Cardiovascular failure⇥ NYHA class II-III , NYHA class IV 0.39 (0.2;0.58) / <0.001
Cardiovascular failure⇥ Malignant haematological disease -0.42 (-0.79;-0.06) / 0.025
WBC (109 /L) (>20)⇥ Neurogenic shock -1.14 (-1.91;-0.38) / 0.003
ALI/ARDS⇥ Cardiogenic shock -0.96 (-1.46;-0.46) / <0.001
Cardiogenic shock⇥ Heart rate (bpm) (<70) -0.35 (-0.61;-0.09) /
0.001
Cardiogenic shock⇥ Heart rate (bpm) (>=120) -0.43 (-0.68;-0.17) /
Cardiogenic shock⇥ NYHA class II-III -0.38 (-0.65;-0.11) / 0.007
(to be continued)
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haematoma, Traumatic intraparenchymal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
⇥ See interaction significance.
PROSAFE project
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Interactions among independent variables
Cardiovascular failure (Hypovolemic (non-haemorrhagic) shock, Cardiogenic shock)⇥ Renal failure (AKIN) (Moderate) -0.39 (-0.65;-0.13) / 0.003
Bilirubin (mg/100ml) (>=1.2)⇥ Renal failure (AKIN) (Severe) 0.45 (0.24;0.67) / <0.001
Serum urea (mg/100 ml) (>=60)⇥ Renal failure (AKIN) (Moderate, Severe) -0.34 (-0.54;-0.13) / 0.002
GCS (3,4)⇥ Severe COPD -0.64 (-1.05;-0.23) / 0.002
Severe COPD⇥ Diabetes with insuline treatment 0.51 (0.21;0.8) / 0.001
Heart rate (bpm) (<70)⇥ Mild liver disease -0.92 (-1.43;-0.41) / <0.001
Urinary tract infection⇥ Mild liver disease 1.36 (0.46;2.27) / 0.003
Max((Age-72),0) in decades⇥ Moderate or severe liver disease -0.61 (-1.09;-0.13) / 0.012
Platelets (103 /mm3) (20-49)⇥ Moderate or severe liver disease -0.51 (-1;-0.03) / 0.040
WBC (109 /L) (>20)⇥ Platelets (103 /mm3) (<20) -1.09 (-1.78;-0.41) / 0.002
WBC (109 /L) (>20)⇥ Systolic Blood Pressure (mmHg) (<100) -0.3 (-0.47;-0.12) / 0.001
WBC (109 /L) (>20)⇥ Platelets (103 /mm3) (<20) -1.09 (-1.78;-0.41) / 0.002
WBC (109 /L) (>20)⇥ Left heart failure with pulmonary edema 0.51 (0.16;0.87) / 0.005
WBC (109 /L) (>20)⇥ Lung cancer 1.95 (0.8;3.09) / <0.001
Dependent variable explained
Likelihood Ratio Test: 11351
Degree of freedom: 155
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.856
GiViTI Calibration Test: 2.59
p-value: 0.107
Polynomial Degree: 2
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haematoma, Traumatic intraparenchymal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
⇥ See interaction significance.
PROSAFE project
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National report for general ICUs - Year 2015
Prognostic models - Adult patients with LOS<24 hours
Model: Logistic regression.
Dependent variable: Hospital mortality°.
Sample used for model development: Patients with LOS<24 hours from general Italian ICUs.
Sample size: 12586 patients.
Independent variables Coefficients (95% CI) Odds Ratio (95% CI) p
Intercept -7.22 (-7.77;-6.67) / /
Miscellanea
Age (in decades) 0.04 (0.03;0.04) 1.04 (1.03;1.04) <0.001
Min(BMI - 28, 0) -0.07 (-0.1;-0.05) 0.93 (0.91;0.96) <0.001
Surgical status (Non surgical vs. Elective surgical) 1.34 (1.09;1.58) 3.82 (2.99;4.87)
<0.001
Surgical status (Emergency surgical vs. Elective surgical) 0.85 (0.62;1.09) 2.35 (1.86;2.97)
Stay before ICU (days) (logarithm) 0.43 (0.35;0.51) 1.53 (1.41;1.66) <0.001
Reason for admission: Monitoring/Weaning vs. Only ventilatory support -0.61 (-0.84;-0.39) /
⇥Reason for admission: Ventilatory and cardiovascular support vs. Only ventilatory support 0.29 (-0.04;0.61) /
Reason for admission: Only cardiovascular support vs. Only ventilatory support -0.17 (-0.69;0.35) /
Physiopatological components
Bilirubin (mg/100ml) (>=1.2 vs. <1.2) 0.29 (0.08;0.51) 1.34 (1.08;1.67) 0.008
Heart rate (bpm) (<40 vs. 40-119) 0.93 (0.4;1.46) 2.54 (1.49;4.32)
<0.001
Heart rate (bpm) (>=120 vs. 40-119) 0.4 (0.15;0.65) 1.49 (1.16;1.91)
HCO3 (mEq/L) (<15 vs. >=15) 0.46 (0.13;0.8) 1.59 (1.14;2.22) 0.006
Systolic Blood Pressure (mmHg) (<70 vs. >=100) 1.71 (1.32;2.09) / ⇥
Systolic Blood Pressure (mmHg) (70-99 vs. >=100) 0.34 (0.13;0.54) /
Urine Output (L/24h) (<0.2 vs. >=1) 1.07 (0.68;1.47) /
⇥Urine Output (L/24h) (0.2-0.49 vs. >=1) 0.57 (0.14;0.99) /
Urine Output (L/24h) (0.5-0.99 vs. >=1) 0.23 (-0.03;0.48) /
PaO2/FiO2 (100*mmHg/%) (100-299 vs. >=300) 0.24 (0.06;0.42) 1.27 (1.07;1.52)
<0.001
PaO2/FiO2 (100*mmHg/%) (<100 vs. >=300) 1.17 (0.74;1.6) 3.21 (2.09;4.96)
Sodium (mEq/L) (<125 vs. 125-145) 0.73 (0.04;1.41) 2.07 (1.04;4.11)
<0.001
Sodium (mEq/L) (>=145 vs. 125-145) 0.57 (0.25;0.88) 1.76 (1.29;2.41)
Serum urea (mg/100 ml) (60-179 vs. <60) 0.27 (0.06;0.48) / ⇥
Serum urea (mg/100 ml) (>=180 vs. <60) -0.99 (-2.09;0.11) /
Platelets (103 /mm3) (50-99 vs. >=100) 0.67 (0.35;1) / ⇥
Platelets (103 /mm3) (<50 vs. >=100) 1.01 (0.49;1.53) /
Clinical conditions on admission
Spontaneous Intraparenchymal bleeding (Yes vs. No) 1.54 (1.06;2.01) 4.65 (2.89;7.48) <0.001
Aneurysm (Non-ruptured aneurysm vs. No aneurysm) -1.57 (-2.7;-0.45) 0.21 (0.07;0.64)
<0.001
Aneurysm (Ruptured or fissured aneurysm vs. No aneurysm) 0.81 (0.12;1.49) 2.24 (1.13;4.42)
Coagulation disorder (Yes vs. No) 1.16 (0.49;1.82) 3.18 (1.63;6.2) 0.001
Digestive tract malignancy (Yes vs. No) 0.59 (0.31;0.88) 1.81 (1.37;2.4) <0.001
Acute severe arrhythmia: bradycardias (Yes vs. No) -1.85 (-2.79;-0.91) 0.16 (0.06;0.4) <0.001
Lung cancer (Yes vs. No) 0.85 (0.32;1.38) 2.34 (1.38;3.97) 0.003
Bowel ischaemia (Yes vs. No) 0.86 (0.26;1.47) 2.37 (1.29;4.34) 0.006
Septic shock (Yes vs. No) 1.12 (0.59;1.65) 3.08 (1.81;5.23) <0.001
Abdominal trauma (Yes vs. No) 1.2 (0.55;1.86) 3.33 (1.73;6.41) 0.001
Comorbidities
Metastatic cancer (Yes vs. No) 0.91 (0.64;1.19) 2.49 (1.9;3.27) <0.001
Mild liver disease (Yes vs. No liver disease) -0.62 (-1.2;-0.05) 0.54 (0.3;0.95)
0.004
Moderate or severe liver disease (Yes vs. No liver disease) 0.56 (0.09;1.02) 1.75 (1.1;2.78)
Organ failures
GCS (3,4 vs. 15) 2.72 (2.34;3.1) /
⇥
GCS (5-10 vs. 15) 0.64 (0.27;1) /
GCS (11-14 vs. 15) 0.33 (0.07;0.58) /
GCS (Not evaluable in the first 24 hours in neurological patient* vs. 15) 1.47 (1.02;1.93) /
GCS (Not evaluable in the first 24 hours in NON-neurological patient* vs. 15) 0.69 (0.4;0.99) /
Renal failure (Yes vs. No) 0.32 (0.09;0.56) 1.38 (1.09;1.75) 0.008
Metabolic failure (Yes vs. No) 0.32 (0.09;0.55) 1.38 (1.09;1.73) 0.008
Haemorrhagic-Hypovolemic shock (Yes vs. No) -1.19 (-1.91;-0.47) / ⇥
Neurogenic shock (Yes vs. No) 2.22 (1.05;3.39) 9.2 (2.86;29.64) <0.001
Interactions among independent variables
Serum urea (mg/100 ml) (>=180)⇥ Platelets (103 /mm3) (>=100) 1.94 (0.75;3.13) / 0.002
GCS (5-10)⇥ Urine Output (L/24h) (0.2-0.99) 0.91 (0.31;1.51) / 0.003
GCS (Not evaluable in the first 24 hours in NON-neurological patient*)⇥ Urine Output (L/24h) (<0.5) 1.34 (0.64;2.04) / <0.001
Systolic Blood Pressure (mmHg) (<70)⇥ Intensive treatment (Only cardiovascular support) -1.39 (-2.28;-0.51) / 0.002
Urine Output (L/24h) (<0.2)⇥ Systolic Blood Pressure (mmHg) (<70) 0.87 (0.08;1.66) / 0.024
GCS (3-4)⇥ Haemorrhagic-Hypovolemic shock 1§ / <0.001
Urine Output (L/24h) (<1)⇥ Haemorrhagic-Hypovolemic shock 1.59 (0.68;2.5) / <0.001
Dependent variable explained
Likelihood ratio test: 8340.5
Degree of freedom: 54
p-value: <0.0001
Goodness-of-fit
Area under the ROC curve: 0.957
GiViTI Calibration Test: 2.26
p-value: 0.132
Polynomial Degree: 2
° For patients transferred to other ICU or to rehabilitation/high dependency care unit in other hospital, it is considered the outcome at the last hospital discharge.
⇥ See interaction significance.
* A neurological patient is a one with an altered consciousness, probably due to a direct brain injury. It is defined by the presence of at least one of these clinical conditions on admission: Cerebral artery stroke,
Vertebral basilar ischemic stroke, Intracranial hypertension, Spontaneous Hydrocephalus, Non traumatic cerebral oedema, Metabolic/postanoxic encephalopathy, Seizures, Brain tumour, Cerebral Aneurysm,
AVM (ArterioVenous Malformation), Chronic Subdural haematoma, Spontaneous Subarachnoid haemorrhage, Spontaneous Intraparenchymal bleeding, CNS degenerative disease, Brain and skull malformations,
Cerebral contusion/laceration, Traumatic diffuse injury without oedema, Traumatic diffuse injury with oedema, Extradural/epidural haematoma, Traumatic Subdural haematoma, Traumatic intraparenchymal
bleeding, Traumatic subarachnoid haemorrhage, Skull fracture, NON-surgical CNS infection, Post-surgical CNS infection, Ventriculostomy-related CNS infection.
§ All patients with haemorrhagic/hypovolemic shock and e GCS 3-4 died. The associated parameter is infinite.
PROSAFE project
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appendIx 2.—For each of the six subsets defined 
by the combination of surgical status (elective 
surgery with planned or unplanned icU admis-
sion, and emergency surgery) and the presence 
or not of chronic end-stage diseases, we report 
the calibration belts followed by the respective 
area under the receiver operating characteris-
tics (auroc) curves and values.
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